Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 17.6;TIME: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favourable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.3 0.0 0.0 21.5 17.6 11.0 2.9 3.1 0.6 1.1 2.3 1.2 7.1 5.1 5.1 0.7 7.0 3.4 0.1 0.0 1.4 0.1 11.5 0.2 6.5 0.0 0.5 10.3 1.0 3.0 0.5 2.5 0.0 0.0 2.7 10.0 0.0 0.0 0.9 1.8 0.0 1.6 0.7 14.5 12.5 0.1 0.0 8.9 0.2 0.0 5.7 0.8 15.4 0.0 1.4 13.1 3.8 1.5 6.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3 3 138123718-138132387 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0" "Cell line enhanced" "Detected in some" "A549: 2.6;BJ: 3.7" "Group enriched" "Detected in some" 6 "pancreatic cancer: 2.5;stomach cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008017 Enhanced "Intracellular and membrane" "HPA008017: AB_1078073" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.48e-2)" "unprognostic (8.79e-2)" "unprognostic (9.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (4.03e-2)" "unprognostic (1.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.48e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 2.5 0.1 0.1 0.1 0.1 25.9 0.1 0.1 0.1 1.5 0.4 0.3 0.1 0.1 0.1 0.2 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 25.0 0.1 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.6 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 ACER1 ASAH3 ENSG00000167769 "Alkaline ceramidase 1" Q8TDN7 19 6306142-6333629 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;skin 1: 38.2;tongue: 17.3" "Group enriched" "Detected in some" 7 "MCF7: 2.2;T-47d: 7.9" "Group enriched" "Detected in some" 7 "head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (1.13e-2)" "unprognostic (2.87e-4)" "unprognostic (5.04e-2)" "unprognostic (6.18e-2)" "unprognostic (8.16e-4)" "unprognostic (7.27e-4)" "unprognostic (2.17e-2)" "unprognostic (1.61e-1)" "unprognostic (1.99e-1)" "unprognostic (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.30e-5)" "unprognostic (2.11e-1)" "unprognostic (4.44e-2)" "unprognostic (4.22e-1)" "unprognostic (2.24e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 2.2 0.1 0.1 3.8 0.1 0.1 0.1 0.0 0.4 0.1 14.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.1 1.4 0.1 0.2 38.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 17.3 3.5 0.1 2.2 0.6 0.4 0.4 0.2 1.0 3.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 7.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 3.6 0.1 3.5 1.6 0.0 0.6 2.3 2.3 0.4 1.0 0.2 0.4 2.0 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ACER2 "ALKCDase2, ASAH3L, FLJ41587" ENSG00000177076 "Alkaline ceramidase 2" Q5QJU3 9 19409059-19452020 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6" "Group enriched" "Detected in many" 7 "BEWO: 16.4;RT4: 40.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.94e-1)" "unprognostic (2.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (2.03e-1)" "unprognostic (3.90e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (7.42e-2)" "unprognostic (8.46e-3)" 17.4 1.7 3.1 0.7 5.9 0.4 20.7 2.3 6.8 1.4 3.5 0.9 5.3 3.0 1.3 3.0 1.8 2.8 1.3 3.2 3.0 1.9 1.6 2.6 1.5 0.6 4.4 0.3 1.3 4.7 2.7 1.6 20.0 4.5 9.4 3.1 1.4 1.8 6.8 2.1 4.0 1.7 2.1 2.9 1.2 41.0 1.3 4.7 0.4 1.8 1.0 0.8 31.3 40.6 1.0 1.2 0.0 3.1 0.0 1.0 0.5 0.6 1.2 2.0 1.1 3.5 0.2 16.4 1.0 0.7 0.4 0.5 0.3 1.0 0.7 0.4 0.1 2.4 0.5 3.2 0.9 1.3 0.6 1.1 0.9 1.5 0.7 0.2 1.0 1.1 3.0 1.2 1.4 3.4 1.7 2.0 1.1 0.9 1.9 0.9 1.5 0.5 1.6 0.6 0.4 0.3 40.2 3.8 0.9 0.2 1.0 0.2 1.4 1.4 1.7 0.3 0.8 0.3 0.5 0.7 0.9 0.8 0.3 0.8 0.7 0.0 0.1 0.0 0.8 3.1 0.2 1.0 0.3 0.3 0.3 0.4 1.0 0.2 0.0 0.0 0.0 1.2 0.3 0.5 3.1 5.9 2.3 6.8 3.0 1.9 4.4 0.3 4.5 4.7 ACER3 "APHC, FLJ11238, PHCA" ENSG00000078124 "Alkaline ceramidase 3" Q9NUN7 11 76860867-77026797 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070087 Approved "HPA070087: " "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (9.54e-3)" "unprognostic (1.37e-1)" "unprognostic (4.06e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (7.13e-2)" "unprognostic (2.35e-3)" "unprognostic (8.45e-3)" "unprognostic (1.30e-1)" "unprognostic (3.68e-3)" "prognostic unfavourable (2.73e-4)" "unprognostic (5.24e-2)" "unprognostic (3.37e-1)" "unprognostic (9.88e-2)" "unprognostic (7.97e-2)" 18.3 5.9 11.8 8.6 19.8 7.1 7.8 7.9 15.2 10.5 10.8 29.5 1.5 12.0 7.0 7.1 9.8 5.4 6.3 5.3 14.7 11.0 9.1 4.9 11.3 8.2 27.3 7.2 4.0 4.6 8.3 3.6 31.6 21.8 8.3 10.0 6.0 6.3 5.0 2.7 6.1 8.1 7.2 22.0 8.7 7.2 9.3 24.6 1.3 6.0 6.5 6.7 5.4 6.5 1.6 4.7 3.9 5.0 0.6 2.2 1.4 4.9 5.9 4.8 5.9 21.9 10.4 3.2 7.3 7.5 6.1 6.7 4.1 5.5 4.6 5.3 5.6 8.8 6.6 7.8 7.5 5.6 2.2 7.2 4.0 2.8 6.1 6.4 12.5 5.3 3.9 7.3 8.2 10.5 4.0 2.3 6.9 4.7 0.5 4.9 2.5 5.8 2.9 16.5 3.1 5.2 5.2 1.7 4.3 8.6 10.0 2.7 7.1 3.9 13.6 6.1 4.6 18.4 5.9 2.0 4.2 6.4 3.9 3.7 7.2 0.6 5.0 3.9 1.2 4.5 1.4 1.6 0.9 1.5 4.7 1.0 0.7 1.0 1.8 0.6 2.8 2.5 2.2 1.4 11.8 19.8 7.9 14.4 14.7 11.0 27.3 7.2 21.8 24.6 ALG1L ALG1L1 ENSG00000189366 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 11.4;urinary bladder: 12.5" "Cell line enhanced" "Detected in some" "CACO-2: 11.1;CAPAN-2: 10.1;HaCaT: 10.8;MCF7: 20.9;T-47d: 14.1;U-266/70: 7.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA036108 Uncertain "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favourable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favourable (6.24e-4)" 0.0 0.5 2.3 0.8 1.6 0.0 1.1 0.3 1.8 0.8 0.9 0.0 0.9 11.4 1.3 2.0 0.4 0.1 1.6 2.0 1.0 1.0 0.7 0.0 2.2 1.7 0.7 0.0 1.2 1.2 1.2 0.6 1.6 0.6 5.9 5.5 0.1 0.2 1.0 0.0 1.1 0.5 1.0 2.3 12.5 0.9 3.1 2.4 4.8 0.2 5.3 5.0 2.1 0.7 0.6 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.1 0.3 11.1 10.1 3.0 4.9 0.0 10.8 0.3 0.0 0.6 0.4 2.6 0.5 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.8 1.0 0.0 20.9 0.6 0.2 4.5 2.7 0.1 0.0 5.0 0.0 0.6 1.7 0.7 0.4 0.1 0.5 14.1 0.2 0.2 0.1 1.7 0.1 0.0 7.9 1.1 4.1 0.1 0.0 0.7 4.8 0.1 0.2 3.9 0.2 2.1 3.1 2.1 4.2 0.0 1.9 2.3 1.6 0.8 5.3 0.0 2.4 5.0 2.1 ALG1L2 ENSG00000251287 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 3.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;HDLM-2: 1.9;HEL: 1.7;Karpas-707: 1.3;REH: 2.8" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 4.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 4.0" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favourable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.1 0.7 4.0 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.5 0.1 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.6 0.3 0.3 0.4 0.1 0.0 0.0 0.0 4.0 0.9 0.1 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 4500000 "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favourable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 19.0 15.2 14.0 15.2 15.7 16.6 15.2 11.9 17.9 12.0 20.3 21.4 26.4 30.2 13.3 21.4 15.6 18.5 23.3 18.8 13.4 8.8 17.5 24.1 15.7 16.8 19.1 10.3 9.3 45.4 13.1 20.4 18.5 17.3 15.8 8.8 14.0 36.8 21.9 6.3 11.1 23.4 8.7 13.2 25.6 23.6 27.2 17.9 10.6 18.7 7.5 16.5 14.8 13.3 5.6 15.7 30.1 19.8 3.9 8.9 7.7 4.0 5.7 2.8 5.3 20.5 11.2 6.9 6.6 8.0 2.9 4.9 1.6 6.3 2.7 4.0 10.7 6.3 0.6 6.0 0.4 1.2 4.3 1.6 6.4 5.7 14.2 2.4 16.8 13.3 11.8 4.7 3.0 6.4 1.7 38.4 5.8 4.6 2.1 2.7 0.8 5.6 1.9 0.2 12.6 4.8 6.3 1.3 4.2 9.3 8.3 4.7 3.7 3.0 11.3 2.0 7.8 7.4 1.9 9.1 0.8 2.1 5.9 2.1 6.7 4.3 13.7 17.1 8.9 16.0 7.9 5.6 6.5 7.3 11.2 5.6 3.9 5.3 30.1 3.9 19.8 15.7 8.5 7.7 14.0 15.7 11.9 17.9 13.4 8.8 19.1 10.3 17.3 17.9 ASAH1 "AC, ACDase, ASAH, FLJ21558, PHP32" ENSG00000104763 "N-acylsphingosine amidohydrolase 1" Q13510 8 18055992-18084998 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 71.3;SK-MEL-30: 101.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 27.0;classical monocyte: 53.6;eosinophil: 36.5;intermediate monocyte: 77.9;myeloid DC: 20.8;neutrophil: 73.8;non-classical monocyte: 80.5" "Group enriched" "Detected in all" 6 "dendritic cells: 20.8;granulocytes: 73.8;monocytes: 80.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005468 Supported "Intracellular and membrane" 410000 "HPA005468: AB_1845062" "unprognostic (1.99e-1)" "unprognostic (1.86e-1)" "unprognostic (4.15e-3)" "unprognostic (9.23e-2)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-2)" "unprognostic (4.29e-3)" "unprognostic (2.44e-1)" "unprognostic (4.85e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-2)" "prognostic favourable (3.08e-8)" "unprognostic (1.95e-1)" "unprognostic (3.91e-2)" "unprognostic (6.54e-3)" "unprognostic (7.36e-3)" 41.9 16.8 18.5 11.2 20.7 20.7 44.2 17.6 19.1 23.9 18.5 15.4 31.5 11.9 17.6 30.6 19.8 16.2 22.3 120.4 17.5 19.2 45.0 13.2 57.2 40.2 27.0 16.7 13.0 16.5 18.0 28.2 36.5 29.8 19.5 19.7 33.3 20.4 39.4 18.2 16.4 16.4 19.5 40.9 25.9 12.9 8.2 15.9 4.5 73.4 15.1 12.3 31.4 16.0 9.8 20.8 73.8 80.5 6.7 6.0 38.7 8.2 11.5 4.5 11.2 71.3 8.4 7.0 8.4 12.0 4.2 7.4 6.1 11.5 5.1 10.8 9.3 10.9 2.8 4.4 5.1 3.9 6.6 22.8 8.7 16.4 19.5 4.6 25.6 18.1 15.3 6.0 4.1 1.1 4.0 10.9 11.9 8.3 2.5 8.3 5.3 7.1 3.3 4.6 6.9 19.7 47.2 7.4 9.9 7.8 25.9 101.4 8.4 5.3 7.3 5.4 7.8 9.9 4.0 13.4 30.3 3.7 16.0 10.5 4.3 27.0 53.6 36.5 6.0 77.9 5.4 9.8 4.5 4.5 20.8 7.7 5.3 4.8 73.8 6.7 80.5 3.9 4.9 38.7 18.5 20.7 17.6 19.1 17.5 19.2 27.0 16.7 29.8 15.9 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50248610 "Enzymes, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "intestine: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" 1200000 "Focal adhesion sites" "HPA061171: " "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.3 1.1 0.6 0.2 0.9 0.0 0.5 0.5 1.3 1.7 0.5 43.9 0.7 0.3 0.7 0.5 0.2 0.9 0.5 1.4 0.6 1.6 0.4 0.2 1.2 1.4 1.5 0.3 1.0 0.4 0.5 0.3 0.9 0.2 0.8 0.7 33.4 0.7 0.6 0.2 2.5 1.1 0.6 0.1 1.0 0.5 0.9 0.9 0.0 0.0 0.0 2.2 0.1 1.8 1.4 1.6 2.2 2.9 1.1 2.0 2.0 1.3 3.8 3.5 1.0 4.6 0.0 2.2 2.7 1.7 2.1 0.7 4.7 2.3 3.8 1.3 3.8 2.9 1.8 0.4 0.2 0.4 2.6 6.5 7.4 0.8 2.5 1.2 2.5 1.5 1.4 0.1 4.8 4.1 0.0 6.4 1.6 2.1 0.3 2.7 7.3 2.5 1.8 3.3 1.5 1.0 2.0 1.9 4.3 4.7 6.0 1.9 0.2 0.0 5.5 0.0 1.7 0.0 0.0 0.0 0.7 0.0 2.2 0.9 0.4 1.7 0.0 0.1 1.4 2.1 0.0 0.0 0.0 0.9 0.6 0.1 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105384 "Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36.8" "Cell line enhanced" "Detected in many" "PC-3: 16.9;RT4: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.9;NK-cell: 16.7" "Group enriched" "Detected in many" 7 "granulocytes: 4.9;NK-cells: 16.7" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles 290000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 3.8 5.4 14.0 3.0 24.5 3.1 7.4 17.2 24.7 15.5 2.3 5.5 2.6 1.5 8.3 6.9 5.4 10.4 7.1 36.8 15.4 21.6 14.3 1.0 10.8 3.5 11.3 16.2 13.8 7.8 6.5 8.5 10.0 17.7 8.9 2.0 7.5 14.8 6.7 1.1 2.2 1.9 7.2 7.6 4.2 7.5 6.2 5.0 1.1 19.5 2.3 3.9 10.5 4.7 1.4 1.4 4.9 0.2 16.7 0.7 0.5 6.6 0.2 3.1 0.1 0.3 1.0 0.1 3.7 3.2 8.1 2.8 4.4 5.0 0.0 14.8 3.0 1.5 0.0 6.4 2.6 0.1 0.0 3.6 2.8 0.0 4.7 0.1 0.1 9.9 1.9 2.2 0.5 11.8 0.0 0.0 3.3 10.7 0.0 0.0 7.4 16.9 0.1 0.0 0.1 3.8 51.5 6.2 0.0 9.3 3.4 2.7 14.2 5.4 0.0 0.1 6.5 0.2 0.1 1.5 0.0 0.0 5.7 0.0 0.0 4.9 0.2 0.0 0.4 0.1 0.4 1.4 0.2 0.4 1.4 0.3 0.5 0.7 0.4 16.7 0.0 1.0 0.0 0.5 14.0 24.5 17.2 24.7 15.4 21.6 11.3 16.2 17.7 5.0 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235449923-235504481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 35.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012502, HPA050662" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA012502: AB_1845228, HPA050662: " "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 5.0 6.3 3.9 4.3 5.1 1.3 8.4 4.7 4.5 5.4 7.6 3.5 5.1 3.3 8.0 8.7 10.3 6.1 9.7 7.9 2.8 2.9 3.7 4.6 3.7 3.1 3.0 3.2 5.9 35.7 9.8 8.9 4.5 4.7 8.3 5.8 8.5 8.7 7.3 21.6 6.1 6.9 16.9 2.5 3.3 9.2 5.8 3.9 4.7 7.1 7.0 5.0 9.7 5.9 1.5 5.7 2.4 2.7 1.9 1.9 1.3 10.0 6.6 7.3 10.8 11.8 10.0 17.6 8.8 8.0 6.7 6.2 5.1 9.0 5.3 11.7 10.0 12.7 14.2 10.3 8.2 10.4 9.8 3.3 8.4 5.8 7.5 10.8 3.7 7.2 6.7 6.9 16.6 10.2 8.1 7.1 6.2 4.8 6.8 3.9 10.4 3.8 7.5 12.2 13.4 4.3 12.0 9.4 12.0 15.3 5.8 7.6 11.1 11.0 10.0 5.9 9.7 9.9 11.8 10.4 8.5 3.2 3.8 7.8 13.6 2.4 2.3 1.1 1.1 2.7 1.7 1.5 0.8 1.9 5.7 1.1 1.0 1.3 0.2 1.9 2.5 3.1 0.5 1.3 3.9 5.1 4.7 4.5 2.8 2.9 3.0 3.2 4.7 3.9 B3GALT1 beta3Gal-T1 ENSG00000172318 "Beta-1,3-galactosyltransferase 1" Q9Y5Z6 2 167868948-167874041 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.9" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.22e-2)" "unprognostic (1.67e-1)" "unprognostic (4.23e-3)" "unprognostic (2.49e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.94e-2)" "unprognostic (8.72e-2)" "unprognostic (6.44e-2)" "unprognostic (2.30e-3)" "unprognostic (8.34e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (3.79e-1)" 0.1 0.6 0.5 0.0 1.6 0.0 0.3 0.9 5.1 0.2 5.6 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.8 0.0 0.1 5.8 0.1 0.9 7.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 1.4 0.8 2.0 0.5 1.0 2.4 0.4 0.0 0.0 2.2 27.9 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.6 1.0 0.0 0.1 0.0 0.4 0.0 1.8 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.6 0.0 0.5 0.0 2.6 2.0 0.5 0.3 0.6 0.3 0.7 1.1 0.7 0.7 0.2 1.4 2.4 1.3 1.5 1.0 0.3 0.8 0.6 0.4 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Group enriched" "Detected in some" 4 "AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA078659: " "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.0 0.0 0.4 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 B3GALT4 "beta3Gal-T4, GalT4" ENSG00000235863 "Beta-1,3-galactosyltransferase 4" O96024 6 33277132-33284832 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.1;SCLC-21H: 3.1;SK-BR-3: 5.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043001 Approved "HPA043001: " "unprognostic (3.71e-2)" "unprognostic (1.33e-2)" "unprognostic (6.02e-2)" "unprognostic (1.00e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-2)" "unprognostic (6.00e-2)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.98e-2)" "unprognostic (1.96e-1)" "unprognostic (1.17e-3)" "unprognostic (6.83e-2)" "unprognostic (1.94e-1)" "unprognostic (1.22e-2)" "unprognostic (3.75e-2)" 7.0 6.9 3.0 9.8 4.0 3.0 6.7 5.3 6.3 7.6 9.0 6.2 13.1 8.0 6.2 7.0 14.0 6.1 9.4 5.7 3.6 3.4 7.1 1.7 6.7 11.9 3.7 3.0 3.1 3.1 5.3 4.4 7.4 4.0 6.5 4.9 6.7 9.1 15.9 2.7 10.9 12.5 4.3 4.6 11.1 7.7 19.0 2.5 14.7 5.6 5.3 9.8 8.6 7.9 7.3 4.1 12.4 8.4 6.3 9.5 5.2 0.0 0.3 0.6 0.2 0.9 1.6 0.8 0.3 0.4 0.0 0.1 0.0 5.1 0.0 0.0 0.7 2.6 0.0 0.2 0.0 2.8 0.3 0.9 0.4 0.0 1.0 0.0 2.7 2.1 1.3 0.1 0.1 0.7 0.0 0.3 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.0 0.0 0.0 0.8 3.1 0.4 0.1 5.2 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.7 12.4 6.9 10.0 9.5 6.7 7.4 6.0 5.9 8.0 4.1 7.3 5.7 5.1 7.3 6.3 8.4 3.3 6.3 5.2 3.0 4.0 5.3 6.3 3.6 3.4 3.7 3.0 4.0 2.5 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.1;RPTEC TERT1: 21.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 15.8" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054092, HPA054684" Approved "Intracellular and membrane" "HPA054092: , HPA054684: " "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favourable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.1 0.3 0.5 3.1 15.8 0.1 1.8 0.3 1.5 3.0 16.2 0.6 0.0 19.4 1.4 1.6 2.3 1.0 12.9 0.2 1.3 1.5 0.6 0.3 0.2 0.1 0.7 0.1 0.7 6.2 0.1 7.9 0.7 2.2 1.0 27.1 2.2 5.5 0.1 0.2 1.1 23.4 0.7 2.0 0.2 3.8 0.6 3.6 1.8 1.1 0.8 14.8 1.1 5.9 0.2 0.2 1.0 0.2 0.3 0.2 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 4.9 0.5 0.0 2.1 0.1 21.5 1.3 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 0.8 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.0 0.2 0.0 0.0 0.5 15.8 0.3 1.5 1.3 1.5 0.7 0.1 2.2 3.6 B3GLCT "B3GALTL, B3Glc-T, B3GTL" ENSG00000187676 "Beta 3-glucosyltransferase" Q6Y288 13 31199936-31332276 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (3.31e-2)" "unprognostic (2.53e-1)" "unprognostic (4.71e-2)" "unprognostic (6.17e-3)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-1)" "unprognostic (2.91e-1)" "unprognostic (3.28e-3)" "unprognostic (6.74e-2)" "unprognostic (5.51e-3)" "unprognostic (2.26e-1)" "unprognostic (5.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.51e-1)" 6.7 3.4 8.6 5.1 18.3 4.4 14.0 2.0 10.8 4.6 4.2 8.9 3.8 3.8 17.2 10.1 4.4 8.6 4.8 23.2 6.5 5.8 9.0 4.6 4.9 4.7 4.3 8.8 7.9 7.5 7.5 4.8 9.1 8.3 5.0 4.7 7.2 5.9 8.8 5.6 4.6 4.0 17.1 4.9 4.5 5.1 4.9 7.7 5.6 6.6 2.7 7.1 3.7 6.0 2.5 0.8 3.1 0.8 2.6 6.9 2.6 2.7 3.9 16.1 2.9 3.1 3.1 2.6 6.8 7.7 8.3 5.9 2.0 7.7 11.1 5.0 7.9 4.6 3.6 4.3 7.8 34.0 6.8 0.7 3.6 2.9 1.9 4.4 6.0 3.6 5.0 4.7 4.1 7.3 1.9 1.8 6.4 3.5 6.5 1.3 4.7 2.4 5.9 5.2 0.4 3.6 3.9 1.5 6.5 5.8 2.8 7.5 1.3 5.1 10.2 8.4 5.7 3.8 6.7 1.4 3.1 4.2 2.7 3.3 11.1 3.1 0.8 2.4 4.8 0.8 6.9 2.5 3.0 5.3 0.8 1.3 2.5 3.3 0.3 2.6 0.7 0.7 1.6 2.6 8.6 18.3 2.0 10.8 6.5 5.8 4.3 8.8 8.3 7.7 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196113-62224731 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles 43000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 18.9 14.3 8.6 10.8 23.0 41.6 17.5 3.1 14.1 18.4 17.9 7.4 5.6 17.9 19.8 8.0 24.5 8.7 18.1 20.9 7.6 11.5 24.4 14.2 23.9 13.9 9.7 7.1 9.0 43.2 5.4 25.9 22.8 9.5 7.5 16.3 14.4 17.2 6.0 5.2 13.0 21.7 16.3 7.6 14.6 12.0 7.0 10.6 27.0 15.6 8.5 18.5 11.8 14.7 8.4 6.8 28.3 5.6 20.3 19.3 8.2 7.6 5.3 8.1 3.5 8.9 4.0 23.3 7.5 8.3 6.0 8.0 10.9 12.4 8.3 6.9 6.9 7.4 5.1 6.3 10.4 17.3 4.1 20.5 2.5 6.4 6.7 12.2 9.2 4.9 11.9 11.5 4.1 8.9 11.1 5.2 7.2 5.8 23.2 18.3 7.7 2.2 42.6 5.6 4.5 11.4 7.5 7.8 5.8 5.3 11.5 8.6 3.3 14.4 10.1 7.3 6.4 12.2 7.4 14.8 5.2 35.9 5.7 21.2 7.0 7.2 4.5 28.3 11.0 4.4 15.6 7.6 8.2 19.3 5.5 8.4 9.9 14.4 11.3 20.3 5.6 6.8 13.2 8.2 8.6 23.0 3.1 14.1 7.6 11.5 9.7 7.1 9.5 10.6 B3GNT3 "B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3" ENSG00000179913 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3" Q9Y2A9 19 17794828-17813082 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.9;intestine: 61.6;placenta: 56.0" "Cell line enhanced" "Detected in some" "A-431: 17.8;BEWO: 17.6;CAPAN-2: 47.7;EFO-21: 12.2;RT4: 17.1;SK-BR-3: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024298 Enhanced "Intracellular and membrane" "HPA024298: AB_1845236" "unprognostic (1.10e-1)" "unprognostic (5.19e-2)" "unprognostic (1.84e-1)" "unprognostic (4.84e-3)" "unprognostic (1.10e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (4.25e-5)" "unprognostic (3.26e-1)" "unprognostic (4.64e-2)" "prognostic unfavourable (2.16e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (7.38e-2)" "unprognostic (1.26e-1)" "unprognostic (7.10e-2)" "unprognostic (2.57e-2)" 0.4 0.2 0.2 8.7 0.3 0.0 1.8 0.2 0.3 3.5 25.3 0.0 12.0 16.6 0.4 1.2 15.1 0.6 69.9 0.5 0.2 0.3 11.4 2.5 1.0 1.2 0.2 0.0 0.3 9.1 0.0 0.3 56.0 0.0 4.4 22.4 0.3 24.4 12.8 0.3 2.0 61.6 1.9 0.2 0.3 21.8 0.3 0.0 0.3 0.4 2.6 18.3 10.2 5.4 0.0 0.0 0.0 0.0 0.0 3.2 0.6 17.8 4.7 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.2 47.7 0.0 12.2 0.0 1.7 0.0 5.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 7.7 0.0 0.0 0.4 10.6 17.1 0.0 0.0 0.0 16.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 8.0;hTCEpi: 9.7;T-47d: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055261: " "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.4 1.0 0.3 2.1 0.2 0.1 1.0 0.1 0.0 0.3 0.6 3.4 0.4 0.5 0.9 0.0 2.0 2.6 2.1 0.1 8.0 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.7 0.1 0.4 0.0 1.5 0.6 0.2 4.8 0.0 0.7 0.6 2.0 0.4 0.6 1.0 1.4 0.6 1.3 1.7 1.5 1.0 0.5 7.5 0.1 0.1 0.5 2.8 0.5 0.3 0.6 4.9 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253244-183298504 "Enzymes, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.8;hTCEpi: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.0" "Region enriched" "Detected in single" 12 "cerebellum: 16.5" "Low region specificity" "Detected in many" HPA017292 Uncertain Approved Nucleoli Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavourable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavourable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavourable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 8.6 1.4 2.2 6.1 2.3 31.6 4.3 1.2 2.5 6.4 29.8 5.4 2.1 17.5 3.2 5.4 23.5 5.4 10.1 3.3 3.0 2.9 3.5 3.0 11.2 5.1 4.0 0.7 4.2 3.5 1.8 5.1 19.8 4.5 3.9 9.2 3.2 8.7 2.5 6.6 8.0 80.2 2.9 6.3 2.3 5.1 2.9 2.3 1.0 4.6 18.9 8.9 5.0 10.6 0.1 1.1 9.0 1.5 0.0 0.3 0.4 16.4 1.6 8.9 5.4 7.4 22.0 8.0 0.2 0.4 1.7 1.4 3.3 8.7 0.0 1.0 0.0 7.6 9.1 25.8 1.4 0.0 5.6 0.8 0.7 0.0 9.5 8.3 4.1 10.3 31.4 1.4 23.5 16.0 9.4 0.0 14.1 0.0 0.0 2.7 3.7 14.3 2.6 4.5 0.0 5.4 4.6 0.4 8.5 4.6 0.0 1.9 0.0 10.1 23.6 0.4 3.5 0.5 4.0 0.0 0.0 0.0 3.3 19.6 8.8 0.0 1.5 1.5 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 0.4 2.2 2.3 1.2 2.5 3.0 2.9 4.0 0.7 4.5 2.3 B3GNT6 B3Gn-T6 ENSG00000198488 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6" Q6ZMB0 11 77034398-77041973 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9" "Cell line enhanced" "Detected in some" "MCF7: 2.0;RPMI-8226: 1.5" "Group enriched" "Detected in some" 14 "colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.3;neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039805 Enhanced "Intracellular and membrane" "HPA039805: " "unprognostic (1.71e-1)" "prognostic favourable (2.31e-4)" "unprognostic (4.79e-2)" "unprognostic (5.42e-2)" "unprognostic (7.64e-2)" "unprognostic (1.95e-1)" "unprognostic (2.72e-1)" "unprognostic (1.23e-2)" "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-1)" 0.2 0.2 0.3 6.6 0.4 0.0 0.2 0.3 0.4 0.5 15.8 0.0 0.0 3.7 0.2 0.0 2.5 0.2 0.9 0.2 0.3 0.3 0.2 0.2 1.4 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 12.4 0.0 1.6 0.0 0.2 0.2 9.4 0.0 0.2 0.2 17.9 0.6 0.0 0.0 0.2 3.4 17.5 0.2 0.3 0.4 0.3 2.3 0.2 0.8 0.5 0.2 0.1 0.0 0.5 0.5 0.0 0.2 0.2 0.1 0.2 0.5 0.1 1.1 0.2 0.7 0.3 0.0 0.0 0.1 0.6 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.6 0.2 0.5 0.4 0.0 0.0 0.0 0.2 0.6 0.0 2.0 0.2 0.5 0.7 0.0 0.0 0.1 1.5 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.1 0.3 0.4 0.5 0.3 0.1 0.2 0.2 2.3 0.2 0.3 0.4 0.2 0.5 0.2 0.2 0.2 0.0 0.4 0.3 0.3 2.2 0.8 0.0 0.3 0.1 0.2 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.0 0.0 0.0 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 14.9;HEL: 11.7;THP-1: 10.4;WM-115: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA035625, HPA035626" Enhanced "Intracellular and membrane" 2100000 "HPA035625: AB_10601118, HPA035626: " "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favourable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.7 0.2 0.8 0.0 0.1 1.0 14.9 1.6 4.5 0.2 3.8 0.2 0.0 0.1 0.2 0.4 11.7 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.2 0.3 0.3 0.1 0.6 0.1 0.5 4.8 2.5 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 0.5 10.4 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.0 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 B3GNT8 "B3GALT7, beta3Gn-T8, BGALT15" ENSG00000177191 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8" Q7Z7M8 19 41425359-41428730 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.3;esophagus: 21.5" "Cell line enhanced" "Detected in some" "HMC-1: 9.8;HUVEC TERT2: 5.3;K-562: 4.3;THP-1: 4.9;U-937: 7.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 29.9;neutrophil: 43.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 43.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA043669 Enhanced "Intracellular and membrane" 43000000 "HPA043669: " "unprognostic (6.89e-2)" "unprognostic (2.46e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (4.11e-4)" "unprognostic (6.44e-3)" "unprognostic (6.51e-3)" "unprognostic (1.84e-2)" "unprognostic (9.92e-3)" "unprognostic (7.30e-2)" "unprognostic (2.56e-2)" "prognostic favourable (9.31e-6)" "unprognostic (5.04e-2)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" 0.7 0.2 0.0 0.9 0.0 2.7 0.7 0.0 0.0 5.0 7.3 13.0 0.9 0.0 21.5 0.4 0.0 1.9 0.0 0.0 1.5 0.0 4.6 0.1 0.0 0.0 0.6 0.0 0.6 0.1 1.3 2.0 2.8 2.2 0.1 2.2 12.5 0.3 0.0 4.3 1.0 0.0 0.3 0.9 1.2 8.4 0.0 1.6 43.3 6.7 0.4 8.1 1.7 0.3 0.0 0.3 0.1 0.5 2.1 0.5 0.6 0.2 0.0 0.1 3.1 0.0 0.1 0.8 1.5 2.1 0.0 0.5 0.0 0.1 0.4 0.0 0.1 1.6 0.7 0.7 9.8 2.6 1.8 0.1 0.1 5.3 4.3 0.3 0.0 0.7 0.0 2.8 0.7 0.1 0.2 0.6 0.0 0.2 1.1 1.3 0.9 0.0 0.2 0.0 0.0 4.9 1.9 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 7.9 0.0 21.7 4.3 29.9 0.7 3.3 8.1 0.0 0.3 1.5 1.6 0.0 0.0 0.1 43.3 0.4 6.7 0.1 0.1 1.7 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148105-67151214 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.5;T-cells: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: , HPA062734: " "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 5.6 7.3 5.0 5.2 7.1 0.6 7.2 0.9 8.8 12.6 5.7 12.4 12.6 3.5 11.7 11.3 6.6 11.4 11.4 11.4 6.0 3.9 7.0 5.0 7.3 4.6 12.2 5.3 20.6 3.1 34.7 17.9 7.9 5.5 12.0 3.6 16.6 8.9 15.9 2.1 4.7 4.4 8.0 5.3 5.0 6.1 9.7 7.1 0.8 25.2 4.6 3.9 8.6 7.9 0.1 1.5 0.2 0.1 0.0 1.9 0.1 2.2 4.1 0.3 0.4 13.5 14.0 0.5 10.6 17.2 6.9 9.0 1.9 0.4 0.3 0.7 16.3 5.2 0.1 0.5 3.8 3.5 1.5 0.3 4.6 1.7 11.0 0.2 0.2 11.6 4.0 6.7 0.2 0.9 0.4 1.3 10.7 1.3 1.2 0.6 2.5 3.7 3.4 6.2 2.0 1.0 2.8 2.4 5.3 24.0 0.1 0.3 0.6 1.8 2.1 12.4 0.5 12.4 4.7 1.6 1.1 0.4 15.5 0.6 6.0 0.0 0.1 0.2 0.9 0.0 1.1 0.1 1.9 1.6 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.6 0.1 5.0 7.1 0.9 8.8 6.0 3.9 12.2 5.3 5.5 7.1 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.6;HL-60: 18.3;THP-1: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved Nucleoli Nucleoli "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 3.7 4.3 6.5 7.2 13.9 17.7 4.0 6.4 10.7 4.7 3.6 4.2 1.7 4.7 6.3 6.1 3.7 8.3 3.9 6.2 6.9 4.7 2.9 3.4 4.4 5.6 3.8 7.1 6.6 7.6 1.7 6.1 3.9 7.1 4.6 2.8 3.7 5.6 4.5 5.0 4.4 3.3 5.1 4.4 6.6 4.9 4.0 3.7 6.9 4.4 4.8 3.3 4.3 3.8 3.7 8.8 16.9 5.7 2.4 11.2 3.3 8.1 5.4 0.1 2.6 1.5 4.9 3.4 3.0 2.6 3.4 2.7 3.2 17.6 4.0 5.8 3.6 1.5 1.3 0.0 3.0 6.1 3.6 8.4 8.0 10.9 5.5 18.3 0.3 1.7 1.5 2.1 3.4 4.1 3.6 3.8 2.7 1.8 5.1 7.0 1.3 4.0 6.7 0.6 0.3 1.9 1.7 1.7 0.6 2.5 1.9 2.5 0.0 17.6 6.8 6.7 4.5 0.9 5.2 0.8 1.9 3.0 7.4 2.4 0.9 2.6 5.7 0.9 2.7 5.0 4.1 2.8 4.3 3.0 8.8 3.7 3.8 4.6 16.9 2.4 2.5 3.5 11.2 3.3 6.5 13.9 6.4 10.7 6.9 4.7 3.8 7.1 7.1 3.7 B4GALNT1 "beta1-4GalNAc-T, GALGT, SPG26" ENSG00000135454 "Beta-1,4-N-acetyl-galactosaminyltransferase 1" Q00973 12 57623410-57633355 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell line enhanced" "Detected in many" "EFO-21: 22.0;HDLM-2: 18.7" "Cancer enriched" "Detected in many" 6 "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008968 Enhanced "Intracellular and membrane" 9500 "HPA008968: AB_1078253" "unprognostic (3.18e-1)" "unprognostic (8.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.33e-3)" "unprognostic (2.54e-1)" "unprognostic (2.70e-3)" "unprognostic (3.73e-5)" "unprognostic (1.26e-2)" "unprognostic (1.72e-1)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (3.18e-14)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (1.44e-2)" "unprognostic (4.92e-4)" 3.0 2.1 12.9 2.3 16.4 1.0 1.5 26.5 32.4 1.9 2.4 1.0 0.0 1.4 2.2 3.8 1.3 1.4 1.5 3.9 15.3 11.2 1.3 1.3 1.7 1.6 6.5 14.3 1.0 1.2 1.1 1.0 1.3 11.6 4.2 2.2 1.6 3.2 6.8 8.1 1.6 1.9 3.2 2.3 1.3 1.4 1.6 2.3 0.0 1.3 0.6 1.8 1.5 0.9 0.0 0.0 0.0 0.0 0.8 1.9 0.0 2.8 14.6 3.2 5.6 0.2 0.0 0.0 1.4 3.0 6.0 6.4 0.9 7.6 0.8 22.0 4.1 1.4 2.5 1.1 2.0 18.7 0.9 0.2 3.7 4.8 0.2 0.7 1.4 0.0 0.4 3.6 0.2 0.1 2.3 4.6 1.0 3.8 0.6 0.0 3.8 2.9 0.0 4.4 2.3 0.0 0.0 12.3 3.1 0.8 0.4 0.1 2.7 1.0 0.0 3.5 8.3 6.9 9.1 11.5 8.6 0.8 8.1 0.9 9.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.9 16.4 26.5 25.9 15.3 11.2 6.5 14.3 11.6 2.3 B4GALNT2 "Cad, GALGT2, Sda" ENSG00000167080 "Beta-1,4-N-acetyl-galactosaminyltransferase 2" Q8NHY0 17 49132460-49176840 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.6;lymphoid tissue: 30.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA015721 Approved "HPA015721: AB_1845245" "unprognostic (4.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.26e-3)" "unprognostic (2.03e-4)" "unprognostic (1.72e-2)" "unprognostic (2.62e-2)" "unprognostic (3.67e-2)" "unprognostic (7.67e-2)" "unprognostic (4.06e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-1)" "prognostic favourable (1.29e-5)" "unprognostic (3.53e-1)" "unprognostic (1.31e-1)" "unprognostic (7.81e-3)" "unprognostic (2.15e-1)" 0.3 0.8 0.4 30.9 0.5 2.2 0.4 0.3 0.5 0.3 19.6 0.3 0.3 0.7 0.3 0.3 0.5 0.4 4.0 0.3 0.3 0.3 8.3 0.3 1.1 0.8 0.3 0.3 0.3 0.5 0.0 0.4 0.7 0.6 0.3 7.9 0.4 1.7 0.3 0.3 1.8 11.9 1.3 1.1 0.8 5.3 0.7 0.3 0.3 10.3 0.3 0.8 0.3 1.4 2.0 1.2 2.3 0.6 0.6 1.6 0.2 1.5 2.9 2.9 5.1 0.1 0.1 1.5 2.2 1.6 0.1 0.2 6.0 2.4 3.5 3.5 0.1 1.6 1.1 0.1 0.4 3.0 3.2 3.8 7.2 3.5 0.1 1.9 6.1 0.3 2.1 0.6 0.3 0.0 2.1 5.8 0.1 1.8 2.5 2.6 3.6 1.5 4.2 1.3 1.1 8.2 2.4 2.7 2.6 1.0 1.3 1.1 3.1 2.5 1.1 3.7 2.3 2.3 1.1 4.4 1.4 3.7 1.3 2.6 1.5 2.3 0.6 0.9 1.1 0.5 0.6 1.3 1.2 0.8 0.5 2.0 1.6 1.5 1.2 0.6 0.3 1.2 0.6 0.2 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.3 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 460364-563509 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 43.1" "Cell line enhanced" "Detected in some" "BEWO: 25.8;HDLM-2: 9.1;HEK 293: 9.1;NTERA-2: 11.4;U-937: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favourable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.3 5.7 1.4 2.1 3.8 1.5 1.1 0.3 8.2 6.1 12.8 0.6 0.4 0.8 8.5 2.9 6.0 3.4 9.6 16.8 5.6 0.9 4.1 0.3 6.2 0.2 0.9 1.7 2.1 7.9 2.5 14.7 0.1 2.0 1.6 9.8 1.5 3.8 1.1 2.7 11.0 1.7 1.9 0.5 0.4 43.1 8.0 0.1 1.0 2.1 9.1 4.1 1.8 4.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 25.8 0.0 0.0 0.0 0.0 6.4 5.0 0.0 0.6 0.0 2.8 6.4 0.7 0.0 9.1 9.1 0.0 0.0 1.3 0.0 0.0 3.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 0.5 0.4 3.5 0.0 6.2 5.5 3.1 2.0 0.6 0.2 0.7 0.6 2.0 0.0 0.0 2.0 0.2 0.6 0.0 0.1 0.1 0.0 11.1 4.3 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.3 8.2 5.6 0.9 0.9 1.7 2.0 0.1 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell line enhanced" "Detected in many" "AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053126 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" "Intracellular and membrane" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA053126: " "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 19.7 11.3 0.0 0.0 4.6 3.5 0.9 1.6 0.5 2.0 0.0 0.0 2.6 0.4 0.7 2.6 4.7 0.5 0.0 6.7 0.0 6.2 6.1 0.2 0.0 4.8 0.3 2.8 0.1 2.1 0.2 6.0 0.0 0.0 5.8 0.2 0.0 17.6 7.7 0.0 0.0 2.6 0.2 0.0 21.9 26.7 1.3 0.9 0.2 7.7 0.0 4.8 1.1 6.3 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 55.7;SiHa: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" 98000000 "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favourable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 32.0 19.5 4.5 22.5 4.5 22.1 35.1 5.9 3.5 25.4 20.4 6.4 29.1 6.5 19.5 34.1 24.7 26.3 24.2 33.1 3.2 2.5 31.7 91.2 34.9 44.9 5.8 2.2 56.8 20.1 30.2 11.9 79.0 5.9 22.6 11.1 32.1 39.1 42.7 15.0 17.6 18.9 17.7 6.4 38.5 19.9 37.6 3.6 23.1 39.3 16.9 41.0 26.4 21.6 24.8 56.4 24.9 9.1 18.2 16.5 5.4 15.9 11.8 2.2 3.0 11.2 19.8 39.9 16.6 20.9 10.0 10.0 7.2 18.6 6.1 10.6 24.2 8.6 2.2 20.6 10.1 55.7 2.2 3.5 49.2 5.5 22.1 2.8 5.9 22.1 36.9 11.4 14.0 10.6 3.9 7.6 9.5 13.9 2.5 5.7 1.3 3.6 3.4 2.0 4.0 30.1 13.9 1.6 2.1 105.0 20.5 4.1 25.9 5.2 9.8 7.2 8.5 23.1 6.4 1.2 2.8 3.8 22.3 3.9 2.6 6.2 9.1 5.0 13.0 7.8 16.5 24.8 8.7 11.4 6.1 20.7 5.3 6.7 24.9 18.2 6.0 56.4 5.7 5.4 4.5 4.5 5.9 3.5 3.2 2.5 5.8 2.2 5.9 3.6 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" 12000 "Golgi apparatus, Vesicles" "HPA007620: , HPA047739: " "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavourable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 18.6 8.6 34.5 10.1 22.4 4.6 15.6 8.1 35.7 18.4 16.1 16.1 10.7 9.4 13.3 8.5 20.2 11.4 11.9 23.3 25.3 18.9 8.4 24.2 7.7 4.4 18.9 15.6 15.3 39.5 9.9 10.6 9.9 12.7 13.5 10.4 8.7 21.4 21.5 41.0 19.5 9.4 21.3 16.1 5.2 11.2 11.4 11.3 1.9 9.0 12.1 10.1 16.5 11.7 1.7 0.4 0.1 0.6 0.2 2.6 0.7 19.8 14.5 15.2 25.8 20.6 18.5 15.2 22.6 18.6 18.0 16.5 9.5 17.6 13.1 11.5 36.0 13.8 13.5 23.1 8.4 13.2 25.7 8.7 10.1 21.8 16.7 8.3 0.3 16.1 27.0 12.9 26.4 20.8 16.4 8.5 14.0 14.3 4.3 8.3 21.1 18.2 15.6 20.4 20.5 12.7 9.3 27.6 22.9 9.9 31.2 15.1 13.6 9.9 16.3 31.3 40.2 21.6 25.1 3.0 5.9 5.6 14.0 6.3 20.9 0.0 0.2 0.0 2.6 0.6 2.4 1.7 1.2 2.2 0.4 0.5 0.0 2.0 0.1 0.2 0.1 0.2 1.1 0.7 34.5 22.4 8.1 35.7 25.3 18.9 18.9 15.6 12.7 11.3 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" 74000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavourable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavourable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 20.7 18.7 16.5 17.2 22.1 17.3 33.4 20.1 23.2 15.0 19.0 12.4 22.2 18.4 13.6 21.0 20.4 17.2 17.5 17.2 13.4 14.7 22.5 21.7 20.8 21.6 16.4 13.4 25.4 37.5 15.8 29.1 41.0 16.6 18.5 19.3 14.8 33.0 27.8 19.5 20.2 15.1 11.7 14.1 26.6 21.5 28.4 16.4 14.8 28.2 10.7 21.4 20.6 22.9 16.7 22.6 7.1 12.6 15.1 25.5 11.9 9.7 6.5 9.6 12.7 14.3 7.3 15.3 5.6 10.0 11.6 10.7 12.7 19.9 9.0 16.0 6.2 9.9 10.1 6.2 6.9 9.4 12.3 5.1 4.3 10.2 10.3 10.1 14.4 10.2 9.2 10.7 11.6 13.1 16.6 20.3 9.4 10.1 6.6 9.7 12.0 13.8 8.0 5.4 22.2 9.8 6.0 13.7 16.2 5.6 14.8 11.7 14.8 18.5 5.5 5.8 10.5 6.5 16.2 73.3 39.5 12.0 8.6 8.7 9.2 5.1 8.9 7.1 17.6 10.1 15.7 16.7 16.7 16.8 10.8 13.5 16.4 15.4 5.9 15.1 12.6 22.6 25.5 11.9 16.5 22.1 20.1 23.2 13.4 14.7 16.4 13.4 16.6 16.4 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119241103 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: " "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 9.6 7.7 7.0 8.6 8.5 11.6 8.8 5.3 6.6 10.1 20.8 8.2 12.6 14.6 15.1 43.4 13.2 12.6 21.3 11.1 6.0 6.2 15.0 11.8 8.9 8.0 7.7 7.3 13.5 20.8 8.5 16.2 23.7 9.1 9.4 17.9 10.2 10.1 16.1 4.8 10.9 40.4 11.3 9.3 8.2 16.8 5.8 6.5 8.5 10.8 6.5 11.4 13.0 8.7 3.7 4.7 11.2 4.6 11.7 12.2 4.8 17.3 33.6 3.9 2.8 12.2 10.2 20.0 38.0 16.8 17.7 17.8 19.8 5.6 3.8 8.0 19.9 23.8 6.6 5.1 17.9 7.3 2.3 5.1 5.6 10.5 8.4 3.0 4.6 7.3 7.1 7.6 6.0 1.7 3.5 3.9 7.3 6.5 1.4 2.6 5.1 9.1 1.4 3.6 1.4 9.7 19.0 3.4 8.0 9.1 4.0 8.2 8.7 1.4 1.2 8.4 7.7 4.2 4.2 8.8 6.9 4.9 7.0 2.8 7.0 11.2 3.7 6.8 12.2 4.6 6.9 3.7 6.0 6.4 4.7 2.9 11.3 6.8 2.2 11.7 4.0 3.1 2.3 4.8 7.0 8.5 5.3 6.6 6.0 6.2 7.7 7.3 9.1 6.5 B4GALT5 beta4GalT-V ENSG00000158470 "Beta-1,4-galactosyltransferase 5" O43286 20 49632945-49713878 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" "unprognostic (7.98e-2)" "unprognostic (5.27e-2)" "unprognostic (2.62e-1)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "unprognostic (1.61e-2)" "prognostic unfavourable (2.69e-5)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "prognostic unfavourable (1.87e-5)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (3.30e-2)" "unprognostic (5.41e-1)" "unprognostic (2.07e-1)" "unprognostic (2.69e-2)" 20.0 37.2 16.2 13.8 15.8 53.3 15.7 22.6 19.0 15.5 16.4 8.5 10.6 16.5 17.2 7.5 27.4 14.6 21.1 32.7 12.4 12.6 16.8 17.3 20.1 7.7 10.4 9.9 19.5 11.7 7.0 14.1 17.8 17.3 12.4 16.1 15.3 15.7 15.7 46.9 6.4 15.5 24.7 13.5 22.6 16.9 16.6 9.3 3.9 9.5 8.0 13.7 19.2 16.0 0.4 1.1 10.2 1.6 1.7 2.4 0.6 16.1 18.6 24.8 10.5 25.9 17.7 21.7 8.0 15.0 36.6 17.6 23.9 20.2 4.9 34.3 13.2 25.8 15.6 11.9 21.6 15.1 4.2 13.1 10.1 14.2 8.1 17.0 25.7 26.4 11.2 15.8 7.6 22.2 21.1 3.1 10.5 8.0 1.0 15.7 12.9 12.1 8.8 21.5 7.1 17.6 11.5 29.6 15.0 28.4 36.4 15.9 8.3 23.4 17.0 22.0 17.8 11.6 16.6 3.8 3.2 12.0 11.4 16.3 13.9 1.3 1.6 3.7 2.2 1.6 2.4 0.3 1.0 2.1 1.1 0.4 0.2 1.5 10.2 1.7 1.6 0.9 1.3 0.6 16.2 15.8 22.6 19.0 12.4 12.6 10.4 9.9 17.3 9.3 B4GALT6 beta4GalT-VI ENSG00000118276 "Beta-1,4-galactosyltransferase 6" Q9UBX8 18 31622247-31685836 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell line enhanced" "Detected in many" "REH: 18.1;WM-115: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020701, HPA058284" Approved "Intracellular and membrane" "CAB020701: , HPA058284: " "unprognostic (3.79e-1)" "unprognostic (4.52e-1)" "unprognostic (6.54e-3)" "unprognostic (2.23e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.31e-2)" "unprognostic (4.50e-2)" "unprognostic (5.18e-1)" "unprognostic (1.13e-1)" "prognostic favourable (5.65e-4)" "unprognostic (2.77e-1)" "prognostic favourable (6.40e-5)" "unprognostic (5.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (4.00e-1)" 3.6 13.8 7.8 2.8 16.0 4.4 2.1 20.6 22.3 2.2 3.5 2.6 0.0 7.7 2.5 2.2 4.8 2.5 7.2 3.8 10.7 7.9 3.7 2.7 1.8 1.2 6.1 10.0 4.3 2.1 7.3 14.8 2.7 16.3 5.8 3.6 13.2 4.6 4.4 3.3 2.2 9.7 1.7 3.1 1.5 3.4 5.4 2.3 5.0 2.1 1.5 1.0 3.6 2.1 0.0 0.5 0.0 0.4 3.8 1.1 0.3 2.3 5.3 9.5 5.3 0.1 0.2 3.5 0.7 0.0 0.1 0.0 9.8 2.0 3.6 4.4 0.9 0.9 5.0 4.2 0.6 14.3 4.4 4.8 0.5 0.2 1.1 8.6 0.8 1.0 0.9 1.4 3.0 5.2 0.7 0.0 0.0 1.4 9.6 0.6 4.1 2.9 18.1 1.6 0.0 1.1 4.8 5.1 7.9 3.4 0.6 6.2 0.6 2.6 5.2 10.8 2.2 0.0 5.8 3.6 0.2 7.5 4.4 7.9 50.1 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.9 0.5 0.0 0.0 1.1 0.0 3.8 0.4 0.0 0.0 0.3 7.8 16.0 20.6 22.3 10.7 7.9 6.1 10.0 16.3 2.3 B4GALT7 "beta4Gal-T7, XGALT-1" ENSG00000027847 "Beta-1,4-galactosyltransferase 7" Q9UBV7 5 177600100-177610347 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042330 Supported "HPA042330: AB_10796576" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (3.12e-1)" "unprognostic (5.97e-2)" "prognostic unfavourable (2.29e-4)" "unprognostic (9.53e-2)" "unprognostic (4.19e-3)" "unprognostic (3.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (2.00e-2)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.44e-2)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" 13.8 33.0 16.0 20.4 14.3 20.7 19.1 10.6 19.6 13.3 12.4 14.9 20.4 16.1 15.5 15.9 11.7 13.3 20.3 17.3 13.7 18.0 16.2 21.3 12.0 21.5 15.1 17.9 16.9 37.0 15.5 23.9 15.3 14.3 16.4 11.7 14.7 22.4 20.9 14.4 12.9 13.7 12.2 10.8 16.3 16.2 16.1 11.7 10.4 16.7 9.8 18.6 13.0 10.2 15.8 16.3 11.2 16.1 8.5 12.5 9.0 8.5 15.1 6.4 15.9 12.7 9.6 28.7 13.3 14.1 12.1 13.9 14.3 13.6 11.0 24.6 13.5 10.2 4.3 28.5 5.3 36.7 11.5 5.8 11.8 9.9 18.4 6.0 10.1 14.6 10.1 13.0 10.6 13.4 5.0 10.6 12.3 19.9 5.0 7.3 6.2 22.3 10.4 4.6 12.0 9.2 13.0 5.6 6.5 6.6 13.4 11.7 8.6 7.0 10.3 15.5 8.9 10.1 13.1 13.3 6.1 7.8 13.1 14.4 14.0 11.2 14.6 7.8 12.5 16.1 11.3 12.8 11.6 11.0 16.3 15.8 10.5 10.3 1.0 8.5 15.3 12.8 7.5 9.0 16.0 14.3 10.6 19.6 13.7 18.0 15.1 17.9 14.3 11.7 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684411-46738261 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles Vesicles "HPA064699: " "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavourable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favourable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavourable (1.58e-4)" 10.6 15.5 10.6 16.7 10.8 14.5 12.9 29.3 21.7 10.8 14.6 9.8 15.8 24.9 14.1 7.5 10.0 15.3 18.9 36.5 11.4 16.8 15.2 12.1 10.6 19.1 21.7 13.1 22.7 23.2 7.2 33.3 7.9 23.9 8.2 12.2 12.3 11.8 11.6 12.8 11.9 25.1 12.5 10.2 14.5 14.0 6.0 6.5 39.2 16.1 8.7 19.5 10.7 17.4 2.0 4.9 3.6 6.9 2.0 16.4 3.6 9.3 5.6 27.4 8.6 15.8 12.0 2.5 16.4 12.8 9.4 6.6 8.2 3.1 13.0 7.7 17.5 6.1 11.5 7.4 9.6 4.6 12.5 5.8 14.2 10.7 11.0 18.2 1.5 9.9 9.6 10.2 3.5 27.9 4.3 16.9 17.2 0.7 12.3 9.1 12.4 6.2 23.0 31.1 14.8 5.6 0.1 25.6 23.3 8.0 3.9 17.2 4.3 13.9 25.3 19.5 10.4 14.3 23.7 17.6 21.2 8.2 20.7 10.4 15.8 0.6 2.6 3.0 9.4 6.0 16.4 1.8 9.9 9.0 4.5 2.0 5.8 5.4 3.6 2.0 6.9 4.9 8.6 3.6 10.6 10.8 29.3 21.7 11.4 16.8 21.7 13.1 23.9 6.5 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell line enhanced" "Detected in many" "AN3-CA: 17.4;EFO-21: 12.7;HEK 293: 17.7;NB-4: 19.0;NTERA-2: 13.0" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.7 10.7 17.4 0.6 0.2 0.3 1.1 0.1 3.0 2.2 8.5 0.6 0.0 12.7 0.8 0.1 7.8 0.3 1.2 0.0 17.7 0.1 0.4 6.4 1.4 1.7 0.2 0.6 0.1 1.0 0.3 0.7 1.1 0.1 2.0 4.4 0.1 19.0 13.0 0.3 0.0 0.3 0.3 2.3 0.0 9.1 9.1 0.4 0.0 7.7 2.9 10.6 0.2 0.0 2.4 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027262 Approved Supported "Nuclear membrane,Endoplasmic reticulum" 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717" "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.7 28.2 23.8 51.0 71.1 43.7 17.8 26.4 38.8 50.3 34.6 29.5 45.7 22.7 44.1 41.4 29.4 33.0 28.1 41.4 30.8 26.9 31.3 19.8 35.8 51.5 35.5 38.8 39.7 36.3 44.4 55.4 31.3 33.5 52.0 62.8 38.8 23.2 20.5 36.5 50.5 26.5 16.2 36.2 54.5 21.9 22.0 34.3 29.1 51.7 30.1 61.6 53.9 24.3 36.5 16.4 32.9 46.4 33.7 37.8 142.5 41.0 15.2 36.9 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.6;skin 1: 29.0;testis: 37.9" "Cell line enriched" "Detected in some" 6 "hTCEpi: 37.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.4 0.0 0.4 0.4 0.4 0.0 1.9 0.4 0.4 6.0 0.4 0.4 0.4 0.0 0.4 0.4 25.6 0.3 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 3.6 0.4 0.4 29.0 0.4 0.4 0.4 0.4 0.0 37.9 0.4 0.4 0.4 0.4 8.5 0.4 11.2 0.0 0.0 1.5 0.6 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.2 0.2 0.0 0.7 0.3 0.0 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.2;NB-4: 38.2;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favourable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favourable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favourable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.0 0.3 0.0 0.7 1.3 3.3 1.5 0.7 7.5 0.8 15.6 11.1 0.0 5.3 6.5 0.1 0.7 13.7 5.1 3.0 0.1 21.2 12.9 0.0 8.5 5.0 8.4 3.5 7.6 0.1 2.2 0.5 0.0 0.3 1.2 38.2 10.2 3.7 18.8 0.2 1.2 2.5 0.0 3.8 5.1 1.6 0.3 5.4 7.4 3.5 0.0 1.1 3.2 7.5 0.0 9.8 7.8 11.9 0.0 23.9 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavourable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavourable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favourable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.3 10.4 23.0 6.5 12.9 10.8 19.5 20.6 17.8 19.8 18.8 24.5 14.7 14.1 17.2 29.1 8.7 10.1 7.9 19.6 22.1 10.3 11.8 8.8 14.8 25.6 11.9 16.0 18.6 12.0 16.3 15.2 18.0 8.8 13.1 24.8 16.2 10.4 32.5 14.8 10.1 13.6 15.1 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 11.2 13.8 17.1 17.0 11.4 12.8 8.9 12.8 12.1 11.3 13.5 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168455862-168775137 "Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044683, HPA063527" Approved Supported Nucleoplasm Nucleoplasm "HPA044683: AB_10965059, HPA063527: " "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavourable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 12.3 13.5 17.7 12.2 17.5 9.6 14.2 28.0 23.2 12.3 24.4 6.5 19.8 22.4 17.4 17.0 12.7 9.8 9.7 26.9 14.5 15.9 12.1 11.7 9.4 12.5 11.0 15.9 15.6 7.3 15.8 14.6 8.3 9.2 12.2 27.1 13.4 6.9 17.1 9.4 20.0 28.3 11.0 8.5 6.9 21.0 11.0 8.1 25.1 24.1 7.4 7.5 11.8 30.5 0.8 9.0 0.7 1.7 1.1 1.7 0.5 5.8 5.2 9.3 10.7 23.1 17.2 0.0 5.9 6.0 6.3 8.5 8.2 12.9 0.0 8.5 5.3 11.1 12.0 13.7 10.6 0.0 8.2 10.7 5.6 5.9 20.3 22.5 5.2 19.2 39.3 13.2 10.4 3.2 5.7 0.0 13.1 6.3 19.7 6.3 8.7 7.6 15.3 17.6 10.1 6.0 17.6 12.9 15.6 5.7 14.7 3.0 13.1 12.8 1.8 16.1 6.7 4.4 10.1 0.1 0.0 0.0 10.6 12.0 10.8 0.7 1.7 0.0 0.3 1.2 0.6 0.2 0.6 0.3 1.3 0.8 1.7 1.3 0.2 1.1 1.0 9.0 0.0 0.5 17.7 17.5 28.0 23.2 14.5 15.9 11.0 15.9 9.2 8.1 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898820 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 125.7" "Cell line enhanced" "Detected in all" "ASC diff: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068" Enhanced Enhanced Vesicles "Intracellular and membrane" 18000000 Vesicles "CAB024930: , HPA031068: AB_10601205" "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavourable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 29.0 125.7 12.0 22.8 19.5 22.1 35.3 11.4 30.0 14.1 50.6 17.4 16.2 29.4 18.2 19.3 20.7 12.7 28.0 32.6 11.5 11.6 88.2 43.8 28.4 38.9 12.3 16.1 23.9 19.2 28.3 16.5 47.7 15.7 18.2 50.5 30.1 20.5 15.1 19.3 28.2 40.6 19.6 11.9 38.8 19.7 14.3 11.2 8.0 18.1 24.9 22.4 23.3 18.7 7.0 16.6 81.1 46.1 12.0 31.2 50.0 14.4 14.9 2.8 12.7 116.2 60.2 6.4 20.8 55.4 22.8 29.7 27.9 38.9 3.1 24.1 38.9 23.1 7.5 14.0 14.3 6.0 7.0 8.2 10.4 48.6 25.9 13.0 33.9 47.8 16.9 14.7 3.3 24.8 8.1 47.8 24.7 29.7 3.3 12.0 2.8 35.4 5.2 14.5 17.2 18.2 12.7 5.6 5.3 34.6 60.6 58.0 14.8 18.7 22.8 45.8 10.7 25.9 16.3 23.6 29.7 2.2 82.5 17.3 18.8 60.6 46.1 81.1 7.5 26.6 31.2 7.0 12.9 13.2 16.6 3.6 4.7 6.9 24.7 12.0 17.7 6.6 23.9 50.0 12.0 19.5 11.4 30.0 11.5 11.6 12.3 16.1 15.7 11.2 DBP DABP ENSG00000105516 "D-box binding PAR bZIP transcription factor" Q10586 19 48630030-48637438 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.2;NB-4: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.49e-1)" "unprognostic (3.68e-3)" "unprognostic (2.16e-3)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "prognostic favourable (5.49e-4)" "unprognostic (2.00e-1)" "prognostic favourable (1.16e-5)" "unprognostic (3.32e-2)" "unprognostic (2.39e-1)" "unprognostic (4.24e-3)" "unprognostic (4.75e-2)" "prognostic favourable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (2.52e-1)" "unprognostic (1.46e-2)" "unprognostic (3.61e-2)" 9.0 22.2 17.3 5.7 30.9 6.0 5.2 32.4 38.1 15.6 7.0 13.1 22.0 16.8 13.0 7.1 7.7 7.6 9.5 15.4 13.6 15.0 8.6 11.2 6.6 11.0 13.5 12.1 22.6 6.9 7.2 15.2 2.9 9.8 8.2 4.0 34.9 36.0 17.4 43.2 21.3 13.5 8.4 9.2 15.7 7.5 8.9 6.7 21.2 22.0 12.6 13.4 8.6 6.6 4.8 6.7 7.4 5.5 1.1 6.7 2.0 1.2 2.1 1.1 5.4 0.8 1.1 1.1 0.3 3.0 0.9 2.3 1.3 12.3 2.5 1.4 1.4 3.0 3.8 0.7 0.7 2.6 1.8 5.1 1.9 0.7 4.0 3.1 3.8 3.8 0.7 0.1 0.6 0.2 0.3 19.2 0.8 1.7 9.6 69.3 0.7 1.5 4.7 0.9 6.5 0.4 0.3 3.6 4.5 1.6 8.1 4.5 1.4 3.1 0.3 2.0 5.8 1.0 0.5 9.0 14.5 4.6 0.9 4.4 1.2 3.2 5.1 7.4 3.4 5.5 6.7 4.8 5.4 2.7 6.7 3.3 4.5 5.5 0.1 1.1 3.0 5.8 5.7 2.0 17.3 30.9 32.4 38.1 13.6 15.0 13.5 12.1 9.8 6.7 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria Mitochondria "HPA076422: " "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.8 10.5 13.9 10.2 60.2 38.9 10.7 41.5 46.7 29.2 35.0 9.6 11.4 11.8 54.0 37.5 15.7 16.1 14.1 32.4 17.2 28.7 8.5 11.5 5.8 36.6 17.0 18.4 38.7 31.6 26.8 15.1 28.7 12.5 13.0 37.3 5.4 8.6 9.2 17.2 15.5 7.9 19.6 7.6 37.0 4.0 9.0 14.5 22.1 34.8 21.9 11.8 24.8 26.1 28.0 8.9 32.2 40.4 9.3 11.0 10.8 30.2 8.5 31.4 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell line enriched" "Detected in some" 20 "T-47d: 48.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA046644: " "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favourable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.7 2.4 0.0 0.0 1.4 0.0 48.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 ENPP7 "alk-SMase, NPP7" ENSG00000182156 "Ectonucleotide pyrophosphatase/phosphodiesterase 7" Q6UWV6 17 79730919-79742222 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 71.1" "Group enriched" "Detected in some" 5 "Hep G2: 2.8;Karpas-707: 5.1;U-266/70: 6.9" "Cancer enriched" "Detected in some" 6 "liver cancer: 6.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024603 Approved "Intracellular and membrane" 440000 "HPA024603: AB_1848174" "unprognostic (4.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.49e-2)" "unprognostic (4.83e-2)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (1.24e-1)" "unprognostic (1.01e-1)" "unprognostic (8.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (5.21e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.3 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUT1 "H, HSC" ENSG00000174951 "Fucosyltransferase 1 (H blood group)" P19526 19 48748011-48755390 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.5" "Cell line enhanced" "Detected in many" "CACO-2: 8.1;HEL: 10.1;hTCEpi: 8.0;RT4: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "unprognostic (2.90e-2)" "unprognostic (3.09e-2)" "unprognostic (8.05e-3)" "unprognostic (4.65e-3)" "unprognostic (2.92e-3)" "unprognostic (8.73e-2)" "unprognostic (2.58e-2)" "unprognostic (3.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "prognostic favourable (3.99e-4)" "unprognostic (1.33e-1)" "unprognostic (3.22e-2)" "unprognostic (8.67e-3)" "unprognostic (3.98e-2)" 2.5 0.8 0.9 0.9 0.9 1.5 1.6 3.5 1.4 0.9 0.9 0.9 0.9 1.0 0.9 0.9 1.5 1.2 0.9 1.4 0.9 0.2 1.1 0.9 6.8 0.9 0.9 0.9 0.9 19.5 1.0 1.7 2.8 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 3.4 7.6 0.9 0.9 0.9 1.0 0.9 0.9 0.9 0.9 0.9 0.9 3.3 0.7 1.5 0.6 0.3 3.2 0.1 0.1 0.2 0.0 0.0 1.7 0.2 0.1 0.2 0.2 8.1 4.7 0.3 0.3 0.2 5.5 1.6 5.0 0.1 0.0 0.8 10.1 0.4 0.1 2.4 0.4 4.5 0.0 8.0 0.4 3.7 3.5 0.5 1.5 0.0 3.7 0.2 6.2 0.9 0.4 0.3 0.0 1.6 0.3 9.7 7.6 0.5 0.4 7.0 0.1 4.6 0.2 3.5 0.3 2.5 0.2 0.3 1.4 3.6 1.0 0.1 0.3 0.3 3.3 0.7 0.5 0.5 0.3 0.3 0.8 0.6 0.4 0.3 0.9 0.6 0.5 2.1 1.5 0.3 0.9 0.2 0.3 0.9 0.9 3.5 1.4 0.9 0.2 0.9 0.9 0.9 0.9 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: , HPA058655: " "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.1 4.4 7.0 8.4 11.1 11.3 3.7 4.5 7.2 4.3 5.9 6.6 3.9 2.5 5.4 5.6 6.1 10.2 4.1 4.4 5.7 3.9 8.3 3.7 7.3 5.1 1.8 3.0 7.8 7.4 1.1 5.4 8.7 7.6 3.4 4.1 1.3 6.5 2.7 9.9 2.9 4.8 5.4 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 3.7 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772291-73780251 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" 840000 "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavourable (6.78e-4)" "prognostic unfavourable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 16.2 9.5 8.9 9.0 9.2 7.8 13.9 7.9 11.8 13.8 7.0 8.2 9.8 4.4 12.5 7.8 14.6 9.0 12.8 14.5 7.3 6.3 9.2 7.4 16.1 18.2 10.4 7.2 13.4 7.9 8.9 7.7 24.0 9.7 9.7 5.6 9.7 9.1 9.8 7.5 6.9 7.9 11.9 8.7 14.2 6.9 18.8 7.4 4.5 10.0 6.8 8.6 10.8 11.1 1.7 2.6 3.9 1.3 7.8 16.0 4.4 14.4 8.0 5.7 11.8 11.3 13.1 1.7 7.4 17.9 9.5 18.5 2.6 7.8 3.3 5.4 12.1 6.2 2.9 7.4 10.5 7.9 6.2 4.5 6.4 4.2 4.4 6.3 14.2 8.7 1.7 9.0 9.3 17.2 4.4 6.0 9.3 1.7 1.1 3.3 2.6 20.1 1.5 3.5 3.9 3.4 2.6 1.7 5.5 6.5 6.9 4.2 4.6 2.8 17.5 12.3 5.3 6.1 9.1 8.0 2.7 0.7 17.3 5.6 4.0 3.9 1.0 1.0 16.0 1.2 11.4 1.7 4.8 11.2 1.3 1.5 3.5 7.4 0.2 7.8 1.3 2.6 1.9 4.4 8.9 9.2 7.9 11.8 7.3 6.3 10.4 7.2 9.7 7.4 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 40.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favourable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 1.1 1.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.8 40.9 0.3 0.3 0.0 7.2 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.9 0.3 0.3 0.3 0.1 1.8 0.0 0.3 2.2 0.3 0.1 0.3 0.0 6.1 0.0 0.1 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell line enhanced" "Detected in many" "HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Supported Vesicles Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.1 2.8 5.1 1.4 0.7 1.3 1.5 6.9 2.2 0.0 3.5 2.4 0.8 1.6 0.1 1.2 10.5 1.6 5.2 1.1 0.1 1.6 20.4 4.6 2.4 0.0 1.7 0.0 2.0 5.2 0.0 1.5 0.7 4.2 13.2 1.9 1.9 3.8 0.0 0.0 1.4 1.1 1.4 0.5 0.8 2.1 0.8 1.2 25.8 1.9 1.0 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.3 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137033010 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 40.4;lymphoid tissue: 10.5" "Group enriched" "Detected in some" 10 "NB-4: 14.1;THP-1: 18.1;U-937: 10.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 40.4" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042780 Approved "Golgi apparatus" "Golgi apparatus" "HPA042780: " "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.4 0.1 0.2 2.5 0.2 5.9 0.2 3.2 0.3 0.2 0.2 0.2 0.2 0.0 1.4 0.2 0.4 0.5 4.4 0.2 0.3 0.3 0.2 0.2 1.5 6.2 1.7 0.2 0.2 0.2 0.0 0.4 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.6 0.2 0.4 10.5 0.3 0.2 0.2 0.2 0.3 0.2 4.6 0.5 0.2 4.2 40.4 18.3 1.5 22.1 16.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.1 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.3 1.5 0.3 2.1 0.3 10.5 4.2 10.3 5.7 4.4 1.2 0.2 0.8 18.3 22.1 0.0 40.4 16.3 3.4 0.2 0.2 3.2 0.3 0.3 0.3 1.7 0.2 0.9 0.2 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell line enhanced" "Detected in some" "MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: " "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.4 9.6 0.2 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell line enhanced" "Detected in some" "A549: 22.6;CACO-2: 6.2;EFO-21: 12.3;K-562: 5.2" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001220 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA001220: AB_1078933" "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.6 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.2 3.1 0.3 12.3 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 5.2 0.6 0.0 0.1 0.3 0.8 3.2 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 GALC ENSG00000054983 Galactosylceramidase P54803 14 87837820-87993665 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism, Sphingolipid metabolism" "Glycosidase, Hydrolase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 35.1;HMC-1: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022196 Approved "Intracellular and membrane" 16000 "CAB022196: " "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (9.39e-2)" "unprognostic (3.08e-1)" "unprognostic (9.70e-2)" "unprognostic (1.73e-1)" "unprognostic (6.56e-2)" "unprognostic (8.44e-3)" "unprognostic (8.08e-2)" "unprognostic (1.84e-2)" "unprognostic (6.00e-2)" "unprognostic (2.13e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-2)" 13.8 17.7 21.2 13.2 32.2 18.9 15.4 16.3 25.5 12.3 15.8 28.8 9.6 30.3 10.7 12.1 6.5 20.1 17.4 19.6 22.0 19.5 20.5 11.1 23.0 18.0 30.7 20.1 17.3 13.6 14.4 12.6 15.6 24.9 14.1 16.9 13.3 8.9 10.1 9.3 9.4 30.2 9.3 33.8 14.3 14.9 21.6 26.1 8.6 23.5 5.8 7.3 12.6 11.4 1.7 5.7 20.8 10.5 9.4 16.3 6.4 0.0 8.2 3.0 0.0 10.2 9.2 0.0 3.7 7.6 3.6 4.3 4.5 35.1 2.1 11.4 3.6 0.5 0.0 0.4 4.4 1.1 0.2 12.1 0.3 0.0 8.4 0.0 33.2 9.0 2.8 2.4 0.0 9.6 4.0 1.6 6.0 0.8 0.0 1.8 2.7 0.9 0.0 0.2 0.1 5.7 3.3 2.8 6.7 10.3 1.7 0.0 8.5 8.3 8.1 0.0 5.6 2.3 0.0 1.7 3.2 0.0 1.0 2.8 8.0 12.8 9.5 20.8 7.5 10.5 16.3 1.7 5.7 7.2 5.7 0.8 4.2 4.9 7.8 9.4 8.0 1.0 3.2 6.4 21.2 32.2 16.3 25.5 22.0 19.5 30.7 20.1 24.9 26.1 GALNS "GALNAC6S, GAS" ENSG00000141012 "Galactosamine (N-acetyl)-6-sulfatase" P34059 16 88813734-88856970 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Dwarfism, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026404, HPA042433" Supported Approved Cytosol "Intracellular and membrane" 2400000 Cytosol "CAB026404: , HPA042433: " "unprognostic (3.16e-1)" "unprognostic (9.98e-2)" "unprognostic (4.03e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (8.08e-3)" "prognostic unfavourable (3.66e-4)" "unprognostic (4.15e-3)" "unprognostic (1.32e-1)" "unprognostic (4.84e-3)" "unprognostic (2.00e-1)" "unprognostic (3.53e-2)" "unprognostic (4.12e-3)" "unprognostic (4.24e-2)" "unprognostic (5.54e-2)" "unprognostic (3.59e-2)" "unprognostic (6.84e-2)" 11.9 14.9 9.3 11.2 11.1 25.0 14.8 12.9 15.4 11.1 15.5 11.5 8.8 13.3 9.0 19.9 10.2 14.8 12.7 12.5 11.2 13.9 13.7 17.8 14.7 10.6 11.8 5.2 11.9 7.3 9.9 13.2 15.6 11.6 10.5 8.3 7.1 10.6 9.0 7.1 10.0 17.2 9.4 9.4 10.4 9.5 27.4 8.8 7.9 14.5 6.1 9.0 11.1 13.0 2.1 7.1 19.3 11.2 2.4 3.1 4.7 2.5 19.3 2.8 19.8 22.3 10.7 19.4 8.1 12.6 8.9 6.9 10.1 16.7 3.2 17.2 13.2 14.9 4.1 6.4 5.4 2.1 6.4 2.0 7.9 5.7 15.0 1.5 13.1 14.9 12.5 9.9 2.8 7.6 4.3 1.9 5.2 14.8 4.0 6.4 6.5 9.0 8.6 2.5 5.3 5.5 5.9 7.3 5.6 19.2 1.8 9.6 12.5 14.2 14.1 19.5 14.9 19.9 4.4 2.0 1.9 5.4 21.1 13.1 11.5 0.9 11.2 19.3 3.1 8.0 2.6 2.1 1.8 2.7 7.1 0.9 1.7 2.1 14.2 2.4 5.6 3.0 3.0 4.7 9.3 11.1 12.9 15.4 11.2 13.9 11.8 5.2 11.6 8.8 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favourable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.1 10.6 10.4 3.3 5.6 8.3 14.9 5.3 6.0 5.0 6.9 3.3 32.0 11.2 3.9 4.7 17.2 4.4 9.3 6.8 43.5 8.5 13.6 21.9 0.1 3.7 20.1 9.7 5.3 8.5 11.1 5.6 32.9 9.1 17.5 25.2 6.6 14.7 11.1 10.2 7.0 14.8 9.6 2.9 36.6 9.5 8.4 6.4 2.5 14.8 7.3 5.9 6.0 39.3 3.6 15.9 0.1 11.4 5.1 0.0 6.0 14.6 12.1 12.8 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 GBA "GBA1, GLUC" ENSG00000177628 "Glucosylceramidase beta" P04062 1 155234452-155244699 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 101.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006667, CAB037171, CAB037289" Supported "Intracellular and membrane" 200000 "CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979" "unprognostic (6.03e-2)" "unprognostic (6.02e-2)" "unprognostic (3.41e-1)" "unprognostic (2.42e-1)" "unprognostic (6.00e-3)" "unprognostic (2.97e-1)" "unprognostic (1.04e-3)" "unprognostic (4.76e-2)" "unprognostic (1.22e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-1)" "unprognostic (2.94e-2)" 19.2 29.7 14.8 13.9 24.5 21.9 15.3 8.7 33.4 16.5 20.1 25.2 18.1 13.8 16.9 30.4 18.9 12.7 16.5 13.6 15.8 18.9 31.8 24.6 17.9 15.4 18.5 16.5 13.1 19.2 101.2 32.1 46.2 28.1 14.4 23.5 25.3 22.3 24.3 6.0 21.6 16.6 17.7 19.3 24.5 14.6 9.7 13.1 13.7 22.2 8.7 17.5 16.3 15.2 7.3 13.9 17.9 22.3 6.6 14.0 12.4 8.5 16.5 5.9 8.0 61.7 13.6 6.8 15.1 53.7 22.5 28.5 9.6 31.3 5.9 16.8 35.3 17.3 8.3 10.7 12.0 12.4 5.8 4.9 10.9 5.2 17.7 5.8 20.6 17.8 9.0 47.3 7.2 20.0 5.1 10.0 26.4 18.5 7.1 2.6 3.7 11.7 6.0 9.6 24.2 15.1 6.6 5.6 7.7 13.2 31.7 33.4 23.8 14.1 15.1 17.0 7.6 21.3 12.0 20.0 16.9 4.6 29.7 5.3 13.0 12.2 21.6 9.1 13.4 22.3 8.7 7.3 10.3 9.0 13.9 5.5 7.4 7.8 17.9 6.6 21.2 7.8 14.0 12.4 14.8 24.5 8.7 33.4 15.8 18.9 18.5 16.5 28.1 13.1 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favourable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favourable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favourable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 8.1 13.5 18.7 18.1 9.1 5.6 19.0 11.1 8.8 11.4 12.0 15.0 6.5 8.8 8.1 6.7 8.6 17.9 7.5 5.7 12.4 12.2 9.4 35.4 16.1 10.1 14.0 23.5 9.6 14.1 9.6 10.1 29.7 9.2 16.9 10.5 8.1 3.8 14.5 19.4 21.5 7.0 7.5 7.4 15.8 19.3 15.3 20.5 6.2 15.7 11.0 10.7 12.7 20.6 12.3 14.9 10.5 13.5 11.5 7.3 7.3 15.5 5.1 9.5 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 GBGT1 "A3GALNT, FS, MGC44848, UDP-GalNAc" ENSG00000148288 "Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)" Q8N5D6 9 133152948-133163945 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 30.0;HMC-1: 28.1;HUVEC TERT2: 11.6;NB-4: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051298 Approved "Intracellular and membrane" "HPA051298: " "unprognostic (4.63e-3)" "unprognostic (8.03e-2)" "prognostic unfavourable (6.22e-4)" "unprognostic (2.70e-1)" "unprognostic (8.87e-2)" "unprognostic (4.38e-1)" "unprognostic (2.97e-2)" "unprognostic (7.43e-2)" "unprognostic (9.04e-2)" "unprognostic (2.27e-3)" "unprognostic (2.35e-1)" "unprognostic (9.50e-2)" "prognostic unfavourable (3.46e-5)" "unprognostic (2.92e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-2)" "unprognostic (6.35e-2)" 10.2 12.9 6.7 13.7 5.7 10.3 15.5 8.1 7.8 5.8 5.6 6.3 4.7 4.1 8.5 5.7 6.7 7.8 9.0 7.2 7.0 4.6 7.7 2.0 11.2 20.4 6.7 4.3 15.8 4.4 5.6 5.6 19.7 8.8 8.4 3.9 16.7 6.3 8.2 2.9 4.2 7.3 8.2 7.2 11.2 21.7 4.3 5.7 1.7 8.1 3.2 11.5 8.3 9.0 3.4 3.2 5.2 11.2 0.9 0.5 2.5 0.0 0.7 0.7 0.0 0.5 0.6 0.2 2.3 1.8 1.3 0.0 0.0 0.4 0.5 7.7 2.2 8.4 5.0 0.4 0.0 0.0 0.2 30.0 0.5 0.0 6.2 1.1 28.1 2.6 0.8 0.3 0.0 11.6 8.7 0.1 0.4 0.1 0.1 13.5 2.4 0.2 2.2 0.2 0.8 0.7 0.1 0.2 0.8 0.0 1.2 0.0 0.0 6.6 7.2 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.1 4.8 0.4 4.7 11.2 5.2 0.2 7.7 0.5 1.7 0.4 0.0 3.2 3.4 0.1 0.1 2.0 0.9 6.4 2.3 0.2 2.5 6.7 5.7 8.1 7.8 7.0 4.6 6.7 4.3 8.8 5.7 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 3.9;bone marrow: 9.6" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052617 Uncertain "HPA052617: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.2 0.2 0.0 0.7 0.0 9.6 0.3 0.6 0.3 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.3 0.4 0.4 0.0 0.5 0.5 0.0 0.6 0.1 0.3 0.0 0.4 0.0 0.3 1.0 0.4 0.0 0.1 0.5 0.3 1.6 0.3 0.0 0.6 0.3 1.0 0.9 3.9 0.7 0.3 1.1 0.1 0.6 0.9 0.8 0.5 0.0 0.0 1.1 1.0 0.0 0.0 0.0 2.1 0.5 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.1 1.7 0.5 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 1.3 0.7 1.3 0.5 0.7 0.1 0.4 0.5 0.0 1.8 1.0 0.5 1.2 0.9 0.2 0.8 0.2 0.0 2.2 0.4 0.5 0.5 1.6 0.1 0.5 0.3 0.6 0.5 1.1 0.7 0.9 0.8 0.5 0.8 0.7 0.7 0.5 0.4 1.0 1.1 0.4 3.9 0.3 0.7 0.9 0.9 0.1 GLA GALA ENSG00000102393 "Galactosidase alpha" P06280 X 101397803-101407925 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000237, HPA000966" Enhanced "Intracellular and membrane" 910000 "HPA000237: AB_1078968, HPA000966: AB_1078969" "unprognostic (7.27e-3)" "unprognostic (1.47e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-1)" "unprognostic (1.60e-1)" "unprognostic (3.15e-2)" "prognostic unfavourable (5.62e-5)" "unprognostic (2.53e-1)" "unprognostic (3.42e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-2)" "prognostic favourable (6.16e-4)" "unprognostic (1.13e-1)" "unprognostic (5.44e-2)" "unprognostic (2.21e-1)" 21.1 22.2 5.2 10.0 6.3 15.6 19.2 6.2 5.7 10.8 12.7 7.3 23.2 14.8 11.7 14.1 9.4 11.5 9.1 10.5 5.2 6.3 28.7 18.9 18.7 12.0 9.4 3.2 9.7 8.3 9.8 10.5 17.9 8.6 8.3 11.2 9.4 9.5 47.7 5.9 8.9 21.3 10.8 11.9 20.8 8.5 4.9 5.8 10.2 8.3 13.4 11.2 12.2 8.9 5.4 15.9 12.8 20.9 3.0 6.1 10.1 7.2 28.4 8.2 8.4 19.0 7.4 3.7 8.3 13.0 15.8 45.2 15.4 11.2 8.0 17.7 8.5 17.3 16.1 9.0 13.7 4.9 11.9 4.4 23.6 18.1 4.9 6.1 81.0 6.5 2.9 18.2 5.3 12.8 6.8 17.7 15.1 12.9 6.1 12.7 12.0 11.5 4.4 10.1 19.5 23.2 14.7 3.0 5.1 19.3 8.2 7.7 3.8 12.6 7.3 5.5 6.6 13.1 6.7 5.4 6.2 6.1 9.5 10.2 6.1 9.5 20.8 6.2 4.6 20.9 6.1 5.4 3.7 5.7 15.9 4.9 3.8 4.7 12.8 3.0 20.8 6.7 4.3 10.1 5.2 6.3 6.2 5.7 5.2 6.3 9.4 3.2 8.6 5.8 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996608-33097230 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 1700000 Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: , HPA069503: " "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favourable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 17.3 33.1 9.6 14.9 14.7 9.5 18.4 8.9 19.8 18.3 21.9 12.1 19.8 21.2 18.3 55.0 12.7 15.2 25.8 13.7 9.7 10.0 35.0 33.2 24.3 25.0 9.2 9.7 18.3 25.3 28.4 16.4 26.5 14.0 13.6 23.7 23.5 21.1 17.7 6.1 12.9 28.3 15.6 9.8 21.4 22.7 10.0 8.0 8.3 26.9 7.7 19.5 18.4 13.6 11.1 45.2 22.7 39.2 6.8 20.9 20.9 5.6 9.8 6.3 7.6 39.1 20.3 136.7 9.1 24.7 11.7 15.1 13.9 13.6 2.8 8.1 18.6 5.5 6.0 11.6 8.7 16.0 5.0 10.9 5.9 7.1 20.1 7.6 11.2 23.4 11.2 10.6 6.3 18.0 9.8 10.6 12.8 6.6 4.5 5.0 4.3 4.3 3.9 4.2 13.0 12.6 8.4 1.9 6.6 11.7 19.0 11.4 12.6 19.9 10.5 7.5 5.2 10.3 7.7 8.4 13.4 0.9 15.9 11.0 5.7 10.5 39.2 22.7 8.3 34.6 11.8 11.1 10.2 9.1 45.2 10.0 5.4 6.5 15.5 6.8 23.7 9.5 20.9 20.9 9.6 14.7 8.9 19.8 9.7 10.0 9.2 9.7 14.0 8.0 GLB1L MGC10771 ENSG00000163521 "Galactosidase beta 1 like" Q6UWU2 2 219236606-219245478 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.0" "Cell line enhanced" "Detected in many" "HHSteC: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043058 Enhanced "Secreted - unknown location" "HPA043058: AB_10806375" "unprognostic (4.30e-2)" "unprognostic (6.93e-2)" "unprognostic (2.68e-2)" "unprognostic (2.08e-3)" "unprognostic (4.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.67e-3)" "unprognostic (3.32e-2)" "unprognostic (4.77e-1)" "unprognostic (2.39e-1)" "unprognostic (8.48e-3)" "unprognostic (3.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.28e-1)" "unprognostic (9.23e-3)" "unprognostic (1.33e-1)" "unprognostic (8.50e-2)" 6.9 5.4 2.7 2.0 3.7 2.3 5.6 1.6 3.3 4.0 5.8 4.6 4.5 1.6 5.3 7.9 2.5 14.3 8.6 3.4 3.1 3.5 18.5 3.5 4.1 2.5 2.1 2.1 6.1 3.1 11.7 6.7 7.4 5.6 4.5 2.0 13.2 5.8 3.0 1.4 2.5 4.4 3.4 2.3 3.9 2.1 57.0 1.4 3.1 5.0 1.4 2.4 4.0 2.0 1.7 2.8 3.2 8.9 1.4 1.8 2.2 2.4 4.3 6.7 5.5 7.4 9.2 3.4 4.1 8.8 5.2 4.9 1.6 6.9 0.8 3.8 3.6 1.3 1.9 4.1 4.1 2.2 3.3 2.5 6.3 3.9 18.4 0.9 4.0 10.9 2.5 4.9 3.0 4.7 1.5 4.8 4.8 3.5 2.1 2.5 1.1 1.2 2.2 3.7 3.4 10.6 1.4 4.3 3.9 3.5 4.8 4.0 7.6 2.2 3.6 4.4 5.4 2.6 2.3 4.7 1.3 1.3 8.1 1.1 11.1 2.0 7.0 0.5 1.1 8.9 0.6 0.6 0.9 1.1 2.8 1.7 1.8 1.3 3.2 1.4 6.7 1.2 0.3 2.2 2.7 3.7 1.6 3.3 3.1 3.5 2.1 2.1 5.6 1.4 GLT6D1 GLTDC1 ENSG00000204007 "Glycosyltransferase 6 domain containing 1" Q7Z4J2 9 135623656-135639540 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 28 "testis: 10.3" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023424 Uncertain "Intracellular and membrane" "HPA023424: AB_1849729" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694488-52706032 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favourable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 18.6 23.7 16.1 14.5 20.9 4.7 21.0 15.3 19.9 29.3 17.3 18.3 22.1 14.6 23.5 26.8 14.1 31.9 19.9 19.3 16.6 17.0 23.2 39.4 16.8 16.0 17.9 14.4 32.4 23.6 24.3 40.8 34.7 18.1 21.1 18.9 19.7 22.0 25.2 11.5 13.0 15.2 18.7 17.4 14.8 16.0 43.3 21.6 17.5 37.8 11.6 14.7 21.8 16.8 8.6 15.7 20.5 8.4 20.1 16.3 6.6 8.1 9.8 19.8 15.6 44.1 56.1 11.1 20.7 32.1 18.3 21.1 4.5 15.6 7.0 5.9 36.0 9.3 12.5 21.3 24.3 12.5 9.1 6.5 17.9 20.7 21.1 9.7 20.6 32.2 19.0 15.7 20.4 27.2 8.3 16.1 24.0 8.4 6.5 15.0 10.1 18.4 5.0 11.3 23.4 21.4 9.0 8.2 14.0 17.3 8.4 14.0 14.2 12.9 19.8 13.3 10.4 19.2 11.5 18.2 20.7 7.7 23.3 15.6 16.7 20.5 8.4 14.1 13.3 5.7 13.2 8.6 16.0 14.3 8.1 6.4 16.3 11.5 4.8 20.1 6.0 15.7 10.6 6.6 16.1 20.9 15.3 19.9 16.6 17.0 17.9 14.4 18.1 21.6 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988984-104064183 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;RPTEC TERT1: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavourable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavourable (1.58e-6)" "prognostic unfavourable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 10.2 5.2 2.2 9.9 3.3 0.2 12.0 0.7 2.4 32.8 10.3 1.4 8.8 2.5 24.5 23.1 13.5 13.3 19.1 18.8 2.2 1.8 3.4 2.8 6.9 2.2 2.1 2.1 25.5 2.5 5.9 12.5 6.9 3.5 19.6 5.3 21.8 6.7 8.3 4.0 2.7 6.7 17.3 2.2 1.0 5.5 7.8 0.8 1.0 26.0 10.9 5.7 11.2 13.1 0.8 0.9 0.2 0.6 0.0 2.1 0.0 0.1 0.2 0.2 8.7 11.4 27.9 0.2 12.5 34.4 3.2 4.2 0.1 0.0 0.3 0.7 14.3 0.0 0.1 4.6 2.8 0.6 3.9 0.2 4.6 0.0 5.1 0.3 0.2 25.8 0.2 3.9 5.5 1.7 0.1 0.5 14.1 0.1 0.2 0.1 1.0 2.6 0.3 13.4 0.1 17.6 0.1 0.5 0.7 13.1 0.3 0.1 2.3 0.2 0.2 5.3 2.5 0.5 0.7 1.5 0.3 0.1 0.4 0.2 0.4 0.0 0.0 0.0 2.1 0.6 0.7 0.8 0.3 1.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.9 0.0 0.0 2.2 3.3 0.7 2.4 2.2 1.8 2.1 2.1 3.5 0.8 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 108.7" "Cell line enhanced" "Detected in many" "BEWO: 43.6;HBEC3-KT: 60.2;hTCEpi: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced "Intracellular and membrane" 23000000 "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavourable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 55.8 16.1 17.8 15.5 18.8 9.6 15.2 8.1 15.2 20.5 10.3 31.7 6.4 8.4 9.5 17.3 39.5 8.8 12.6 13.8 18.0 12.6 7.5 13.2 24.8 30.2 22.4 13.0 12.2 9.3 11.7 5.6 108.7 18.9 11.9 14.5 14.1 13.3 10.4 3.9 42.8 11.2 10.9 35.9 28.5 8.2 8.9 15.3 21.9 7.1 25.9 39.7 21.0 32.0 15.9 19.0 4.2 19.4 1.9 3.3 8.0 4.5 3.0 3.2 15.0 20.9 10.4 43.6 7.2 15.5 4.0 5.4 6.1 5.3 14.7 7.5 5.5 12.5 3.5 60.2 5.7 8.2 2.1 2.3 3.7 7.6 5.1 3.8 24.7 13.9 60.1 5.1 3.4 5.7 2.3 6.4 6.2 1.9 8.0 3.6 2.1 6.7 3.6 1.5 9.2 3.8 8.9 0.8 2.8 5.9 27.9 11.8 6.3 4.5 5.0 9.8 3.8 8.0 2.1 15.9 18.9 40.3 11.2 6.1 4.0 3.5 19.4 1.1 1.9 6.5 1.4 14.9 2.3 2.0 19.0 15.9 3.3 2.5 4.2 1.9 1.4 13.7 2.4 8.0 17.8 18.8 8.1 13.9 18.0 12.6 22.4 13.0 18.9 15.3 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340919-72376476 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054583 Supported "Intracellular and membrane" 20000000 "HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favourable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 30.1 37.4 23.1 18.0 22.9 35.5 37.8 23.3 28.1 30.6 20.5 19.4 30.1 18.5 25.9 65.7 11.7 21.8 29.2 33.8 23.4 12.8 34.6 29.5 43.9 31.4 24.9 21.1 20.9 22.2 18.1 22.9 37.9 18.8 18.1 26.0 26.9 24.8 22.0 17.7 17.9 24.6 23.4 21.4 31.5 22.6 18.0 22.9 12.1 31.2 11.1 16.4 26.7 17.1 16.1 37.9 22.4 32.7 17.8 18.1 21.3 7.4 12.7 5.5 10.5 45.0 51.4 7.8 10.5 53.3 22.8 36.5 6.7 54.8 6.2 10.1 21.0 15.0 14.4 6.7 14.5 5.0 5.8 7.8 12.6 11.5 34.9 18.7 22.4 43.7 20.0 9.9 17.8 20.8 12.1 38.8 30.3 6.4 4.0 9.4 3.1 0.1 4.2 11.9 14.0 25.5 11.8 4.7 5.2 26.3 24.8 59.3 4.6 23.6 10.4 34.2 14.3 31.4 11.1 20.7 27.9 6.5 12.4 25.0 16.5 8.9 32.7 22.4 18.1 13.7 15.8 16.1 12.0 15.8 37.9 15.6 9.5 14.0 3.1 17.8 4.8 14.4 10.7 21.3 23.1 22.9 23.3 28.1 23.4 12.8 24.9 21.1 18.8 22.9 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 174.3" "Cell line enhanced" "Detected in many" "ASC diff: 112.8;BJ hTERT+: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" 43000000 "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavourable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 48.0 21.9 7.7 13.6 11.6 11.1 26.1 7.4 11.2 25.8 34.2 9.5 18.0 21.6 22.1 77.3 20.6 17.3 28.1 46.3 7.1 9.1 30.4 44.5 40.9 19.3 8.5 6.7 22.7 30.4 21.8 14.3 174.3 9.3 22.6 26.3 21.0 34.6 13.3 21.0 15.3 33.6 21.0 8.7 20.5 20.7 16.2 6.1 10.8 33.7 15.2 15.4 24.0 19.7 8.9 59.8 23.8 65.9 7.6 16.4 42.9 21.1 16.7 5.8 19.2 112.8 34.8 19.0 26.0 84.4 25.4 55.2 19.5 27.7 0.0 20.7 21.3 17.0 6.2 26.5 33.6 11.8 11.2 2.8 16.2 14.7 33.1 2.3 22.9 30.7 15.6 26.7 17.9 29.1 7.8 34.7 27.8 21.5 2.7 5.3 5.4 7.5 6.4 8.5 27.6 17.5 19.4 3.8 4.7 20.2 13.7 25.1 14.5 15.7 17.2 16.8 4.2 30.8 24.0 16.1 27.6 0.1 38.2 20.8 30.4 14.5 65.9 18.6 14.2 24.5 16.4 8.9 11.7 13.1 59.8 5.5 11.2 10.9 23.8 7.6 14.6 18.0 13.7 42.9 7.7 11.6 7.4 11.2 7.1 9.1 8.5 6.7 9.3 6.1 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367510 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved "CAB003673: AB_425440, HPA044884: " "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favourable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 21.1 19.4 19.0 11.1 22.4 6.4 29.7 12.5 17.2 18.2 17.3 23.9 14.2 10.0 19.4 30.0 17.8 14.3 17.7 15.8 19.7 16.9 21.3 52.6 15.3 11.5 32.1 14.6 29.1 14.3 19.6 10.5 24.9 19.5 18.0 11.0 15.9 16.1 17.4 12.4 28.8 13.1 18.9 39.0 9.1 11.8 10.4 23.3 8.8 21.2 12.3 9.9 19.9 22.8 4.0 5.6 0.9 5.6 9.8 19.5 3.7 5.9 2.6 2.8 3.1 22.0 16.5 5.4 19.5 12.0 4.3 5.8 1.1 4.0 6.0 8.4 7.6 26.1 3.5 11.0 5.3 11.2 5.8 4.6 3.5 1.3 16.9 8.4 3.2 15.7 20.9 6.9 19.8 4.2 3.7 8.6 11.4 2.4 9.3 3.9 3.3 9.8 6.3 8.1 8.5 11.9 3.8 3.5 6.8 9.4 4.6 8.4 2.5 4.8 10.0 18.4 4.4 6.1 8.5 37.6 17.1 3.4 13.8 5.2 5.4 0.0 3.7 0.3 4.8 5.6 19.5 4.0 10.2 7.6 5.6 3.6 7.3 4.6 0.9 9.8 2.6 2.8 12.9 3.7 19.0 22.4 12.5 15.9 19.7 16.9 32.1 14.6 19.5 23.3 LCT ENSG00000115850 Lactase P09848 2 135787840-135837180 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "intestine: 255.5" "Group enriched" "Detected in some" 5 "MOLT-4: 6.8;RPMI-8226: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Region enriched" "Detected in single" 16 "hippocampal formation: 17.3" "unprognostic (2.21e-2)" "unprognostic (1.65e-4)" "unprognostic (2.54e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" "unprognostic (8.03e-4)" "unprognostic (3.55e-3)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (3.57e-1)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (1.64e-4)" "unprognostic (4.90e-2)" "unprognostic (8.92e-2)" "unprognostic (8.97e-2)" "unprognostic (1.02e-1)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 209.8 0.0 0.0 67.7 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 255.5 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.8 1.1 0.0 0.0 1.6 0.0 13.6 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.0 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.4 6.5 5.4 12.1 25.1 27.9 2.8 7.6 13.2 5.0 8.6 2.3 5.4 2.7 1.0 6.5 5.9 6.1 16.8 4.6 11.2 3.4 6.7 3.6 3.5 8.8 4.6 31.6 25.1 7.5 20.5 7.8 9.5 9.2 24.3 3.6 2.1 4.3 4.0 5.6 6.6 6.0 10.0 17.0 12.5 3.5 15.1 11.9 2.7 6.6 17.3 1.6 2.6 6.7 7.9 7.1 5.0 6.6 38.2 29.5 5.1 11.1 8.3 5.8 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: " "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favourable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 11.9 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.1 17.2 2.5 11.8 10.3 14.8 8.3 1.9 16.6 3.7 9.1 6.3 3.4 9.6 16.0 9.2 13.4 9.5 11.1 8.9 6.2 11.2 5.3 3.8 0.0 10.0 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 LPIN3 "LIPN3L, SMP2" ENSG00000132793 "Lipin 3" Q9BQK8 20 41340920-41360582 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 6.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.8;NK-cells: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051466, HPA052667, HPA070640" Approved Supported Cytosol Cytosol "HPA051466: , HPA052667: , HPA070640: " "unprognostic (2.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (9.74e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (6.91e-3)" "unprognostic (4.26e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.74e-4)" "unprognostic (4.29e-2)" "unprognostic (7.79e-2)" "prognostic unfavourable (1.14e-5)" "unprognostic (5.60e-3)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-3)" 11.6 3.7 3.0 8.1 5.2 0.1 23.4 1.5 3.0 10.9 29.2 2.8 13.5 26.8 12.8 21.6 16.3 7.5 11.2 8.8 3.6 0.7 28.2 14.4 4.5 1.6 2.8 3.7 7.9 7.4 8.1 6.7 4.4 4.2 10.1 8.8 8.7 11.0 15.1 1.8 26.1 49.1 5.5 2.4 2.7 7.4 2.5 1.5 1.2 14.2 10.6 9.0 8.0 12.5 0.9 0.7 1.8 0.9 6.3 0.8 0.2 6.8 6.7 0.4 4.0 11.0 17.1 5.2 4.2 5.9 5.1 7.0 12.5 6.1 0.3 5.3 9.3 17.4 2.0 11.0 3.2 0.1 3.9 0.3 9.4 6.3 1.8 0.0 4.7 12.3 14.0 8.7 3.4 1.3 1.7 0.2 6.4 14.6 0.0 0.1 0.6 6.9 0.0 0.1 0.4 18.1 8.6 0.5 0.1 5.6 7.2 3.6 8.5 3.4 0.4 0.3 1.7 5.8 0.0 3.4 1.8 0.0 0.1 0.1 0.3 1.8 0.5 0.7 0.5 0.5 0.8 0.6 0.7 0.4 0.3 0.9 0.7 0.6 1.8 6.3 0.9 0.7 0.5 0.2 3.0 5.2 1.5 3.0 3.6 0.7 2.8 3.7 4.2 1.5 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 33.8" "Cell line enriched" "Detected in single" 9 "HEL: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 NAGA D22S674 ENSG00000198951 Alpha-N-acetylgalactosaminidase P17050 22 42058354-42070842 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "classical monocyte: 38.5;intermediate monocyte: 47.6;myeloid DC: 37.9;non-classical monocyte: 46.1;plasmacytoid DC: 23.2" "Group enriched" "Detected in all" 9 "dendritic cells: 37.9;monocytes: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000649 Enhanced "Intracellular and membrane" 2300000 "HPA000649: AB_1079448" "unprognostic (3.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.45e-3)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (1.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.93e-1)" "unprognostic (3.64e-2)" "unprognostic (3.68e-2)" "unprognostic (1.92e-3)" "unprognostic (8.95e-2)" "unprognostic (2.53e-1)" 23.7 13.5 12.1 20.3 14.5 11.3 12.5 11.8 10.3 16.3 18.3 15.0 10.7 13.2 18.9 16.1 14.5 17.3 16.5 15.8 10.1 8.6 17.9 28.2 19.9 32.6 12.6 7.3 18.1 9.5 27.8 13.1 45.3 11.5 15.2 18.0 19.8 16.6 14.5 9.2 9.9 25.6 18.7 11.4 22.0 14.1 9.3 13.2 12.0 15.0 11.4 17.9 17.3 14.5 2.1 37.9 4.9 47.6 3.4 3.4 19.2 9.0 4.6 7.4 13.1 12.9 14.8 5.4 7.5 15.4 12.9 13.5 10.3 13.4 4.4 4.6 16.2 6.4 5.6 9.1 7.7 10.1 7.1 10.9 7.1 6.9 7.5 9.0 65.2 10.1 8.0 11.6 4.9 21.3 4.0 18.9 10.2 10.5 3.3 3.7 1.9 6.2 7.5 3.7 7.8 10.0 10.8 2.3 2.6 9.9 9.1 9.8 13.6 16.7 11.4 9.1 11.1 5.8 6.7 10.5 10.5 3.5 9.7 17.3 11.2 4.9 38.5 4.6 2.8 47.6 2.8 2.1 2.9 2.6 37.9 1.5 1.9 1.8 1.9 3.4 46.1 23.2 3.4 19.2 12.1 14.5 11.8 10.3 10.1 8.6 12.6 7.3 11.5 13.2 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862906 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" 86000 Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 10.5 30.2 8.6 9.4 11.1 5.2 10.5 15.5 14.6 13.4 14.1 7.4 16.1 14.1 9.8 13.9 9.0 8.3 16.1 9.8 8.0 9.5 29.7 24.2 16.1 7.2 9.4 6.6 12.7 20.6 13.6 16.5 19.8 10.3 15.1 9.1 14.7 18.1 13.8 10.0 9.1 23.5 9.8 4.7 13.4 12.7 6.5 10.0 5.8 22.7 7.0 9.6 13.6 9.5 4.2 7.7 15.2 13.4 3.0 5.1 7.4 2.9 3.0 3.0 6.9 10.1 3.8 5.9 2.7 9.3 8.1 11.8 17.4 3.3 1.0 7.0 3.6 1.7 6.3 2.5 3.1 2.5 4.2 1.5 1.8 20.3 18.1 1.9 8.5 6.3 4.7 9.7 5.0 7.2 3.2 7.2 4.1 5.3 1.6 2.9 2.3 2.4 2.1 1.6 10.4 13.3 6.5 2.3 1.3 3.0 4.0 7.1 7.7 8.7 3.0 5.3 3.1 7.4 4.8 8.9 14.2 2.1 3.9 4.8 3.7 6.4 13.4 8.7 5.1 10.3 4.2 3.9 3.9 4.1 7.7 4.2 4.0 3.9 15.2 3.0 9.2 4.3 4.8 7.4 8.6 11.1 15.5 14.6 8.0 9.5 9.4 6.6 10.3 10.0 NEU2 SIAL2 ENSG00000115488 "Neuraminidase 2" Q9Y3R4 2 233032672-233035057 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 6.1" "Group enriched" "Detected in some" 4 "A-431: 1.1;BEWO: 1.6;PC-3: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.2;hippocampal formation: 1.1" CAB022336 Uncertain 9000 "CAB022336: " "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988134-75018893 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038729: , HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favourable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 5.4 13.4 3.7 10.5 6.9 17.0 5.4 7.9 9.1 4.0 3.9 3.0 4.1 3.6 5.4 4.8 3.9 4.4 3.6 5.9 4.0 4.5 4.3 6.7 8.7 9.0 3.8 6.6 7.2 7.3 15.1 11.2 3.1 4.2 9.7 5.4 5.6 4.8 4.6 19.1 6.7 4.7 4.0 3.5 5.5 5.1 44.6 3.0 19.0 6.8 3.5 7.5 4.5 3.1 3.2 3.8 5.8 6.4 1.2 4.2 2.2 4.6 4.0 3.4 6.6 2.6 2.5 3.8 4.5 2.9 5.2 4.0 13.7 3.9 13.3 4.6 3.6 4.3 8.3 5.8 7.9 7.0 4.4 11.0 7.5 5.6 2.9 17.2 10.6 3.0 4.9 5.2 8.1 3.7 17.7 10.0 5.9 5.0 16.9 8.9 4.2 5.4 14.9 9.0 11.7 6.4 4.9 6.3 4.0 6.9 4.6 20.3 9.9 4.5 5.6 6.5 6.5 4.3 4.5 8.3 8.0 26.7 1.9 8.9 5.5 2.1 6.4 5.8 4.1 3.7 3.0 2.8 3.2 3.9 3.8 3.2 3.5 4.2 3.3 1.2 4.6 2.7 2.3 2.2 3.7 6.9 7.9 9.1 4.0 4.5 3.8 6.6 4.2 3.0 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533083-71575897 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: " "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavourable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favourable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavourable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favourable (6.85e-7)" 26.1 24.0 33.3 39.7 36.6 38.7 33.7 75.7 43.8 25.0 23.0 22.0 31.1 22.5 36.7 48.3 24.3 33.4 21.2 25.1 29.3 15.4 27.4 20.3 31.0 47.9 30.2 25.6 42.8 46.1 26.5 34.5 19.5 26.6 34.2 30.3 29.9 35.9 30.9 35.0 45.4 38.4 31.1 32.3 56.7 28.2 11.8 36.6 35.7 34.1 27.6 41.4 24.9 31.0 9.7 7.6 3.2 7.2 12.5 9.9 6.0 14.3 13.5 17.5 15.3 18.9 17.4 11.8 11.0 19.9 12.0 18.5 14.2 16.5 17.1 7.8 13.5 17.9 19.1 10.8 14.8 14.6 19.6 10.8 32.1 10.1 14.3 22.2 17.9 16.6 22.0 13.1 24.8 11.1 10.9 59.5 11.4 12.2 17.1 26.7 11.6 18.4 17.0 19.6 21.9 18.5 16.7 9.0 7.9 17.1 11.4 10.6 8.4 15.1 12.9 13.0 10.6 13.5 6.4 16.3 11.7 20.6 9.1 23.4 7.9 3.2 5.3 2.3 9.9 7.2 9.0 9.7 8.3 8.0 7.5 8.5 9.7 9.5 2.4 12.5 6.5 7.6 7.6 6.0 33.3 36.6 75.7 43.8 29.3 15.4 30.2 25.6 26.6 36.6 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.3 8.6 3.9 3.1 4.3 8.8 5.6 6.2 12.5 7.0 11.2 3.8 7.7 7.2 8.3 8.6 12.5 2.5 6.5 5.9 7.2 5.6 7.1 10.7 4.7 7.8 20.1 6.2 9.2 8.0 5.5 7.1 8.7 8.4 6.1 9.2 6.5 2.5 7.9 2.5 4.3 3.2 3.8 16.4 10.9 8.2 2.3 4.4 5.7 9.2 10.8 9.9 14.7 6.6 9.5 3.1 2.4 12.5 6.1 11.0 6.4 8.4 22.7 6.8 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 PIGM GPI-MT-I ENSG00000143315 "Phosphatidylinositol glycan anchor biosynthesis class M" Q9H3S5 1 160024953-160031991 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047418 Uncertain "HPA047418: " "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (9.89e-2)" "unprognostic (2.88e-2)" "unprognostic (2.69e-3)" "unprognostic (1.52e-1)" "unprognostic (3.85e-2)" "prognostic favourable (3.27e-4)" "unprognostic (2.63e-2)" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (8.55e-2)" "unprognostic (1.69e-1)" "unprognostic (2.06e-2)" "unprognostic (1.50e-1)" 6.5 9.1 7.4 6.7 9.9 2.9 9.7 7.7 8.7 7.9 6.7 17.1 8.8 7.8 7.3 11.7 8.0 7.3 7.7 6.2 7.6 6.7 7.7 14.9 6.6 7.1 17.3 5.2 8.8 18.3 14.9 10.4 6.2 12.6 11.3 7.9 10.2 10.5 9.1 3.0 9.8 8.4 5.8 21.8 8.0 9.1 9.6 12.5 14.9 11.0 3.1 7.5 7.8 6.1 6.2 10.4 8.3 14.6 9.5 10.6 7.7 5.0 4.5 5.7 8.1 7.4 6.2 1.9 7.5 4.8 5.1 4.7 2.5 9.3 3.6 6.2 4.9 10.2 6.1 6.1 6.5 7.5 6.5 8.2 5.9 3.7 4.5 10.4 6.4 5.5 4.0 6.0 4.7 4.2 4.3 6.7 5.8 8.4 6.7 5.6 5.8 6.5 2.1 5.7 15.4 5.5 6.9 7.9 12.2 8.3 9.8 5.9 18.4 12.5 5.9 6.7 5.9 10.0 4.6 12.2 13.4 0.2 6.1 5.4 7.4 8.3 14.6 5.6 8.1 11.4 8.4 5.8 8.3 6.4 8.8 6.2 10.6 8.3 2.6 9.5 14.2 10.4 8.5 7.7 7.4 9.9 7.7 8.7 7.6 6.7 17.3 5.2 12.6 12.5 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favourable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.3 5.6 4.5 3.9 8.8 10.9 3.8 6.5 15.3 6.1 7.5 3.1 19.3 5.5 5.9 8.0 16.7 2.4 7.5 7.6 9.4 4.0 4.8 7.5 7.7 9.9 8.8 12.0 11.2 31.2 8.4 10.3 4.6 8.8 8.9 11.0 5.2 4.3 5.0 6.8 4.5 3.1 5.3 10.5 9.7 2.4 6.5 3.5 6.3 3.2 6.2 10.8 4.4 7.7 11.1 4.8 5.4 2.2 3.1 2.1 3.0 9.1 9.4 6.5 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946343-196969060 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 26.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.3" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058599, HPA059920" Approved Uncertain Vesicles Vesicles "HPA058599: , HPA059920: " "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.6 3.1 5.7 5.3 8.6 1.9 3.4 18.5 16.3 3.3 26.5 3.2 2.0 2.9 2.3 1.7 3.2 2.8 4.5 6.4 5.3 7.5 1.6 1.6 3.1 2.0 4.4 6.4 0.8 5.9 2.7 2.9 2.1 10.8 4.6 24.5 4.3 4.7 4.6 10.0 4.5 7.4 5.3 2.8 1.8 3.1 1.4 3.0 3.2 1.7 2.8 2.1 9.9 2.9 0.1 1.6 1.4 3.3 0.0 0.2 0.3 2.0 1.4 0.8 3.3 9.1 4.4 0.8 3.0 8.5 2.3 1.9 1.9 1.7 0.3 6.0 6.7 3.4 0.2 0.4 0.6 0.6 0.4 0.9 0.7 7.3 4.3 0.0 3.4 4.4 6.5 0.3 1.1 2.8 0.2 2.6 2.2 3.6 0.3 1.7 0.1 1.1 0.5 0.1 0.6 3.5 3.8 1.3 1.5 4.2 0.3 1.6 8.4 2.9 6.9 1.9 0.5 5.5 1.0 1.2 0.2 0.1 0.4 1.2 0.7 0.0 1.1 0.8 0.2 3.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 1.4 0.0 1.4 0.3 0.0 0.3 5.7 8.6 18.5 16.3 5.3 7.5 4.4 6.4 10.8 3.0 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55535050 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 91.2;fHDF/TERT166: 27.7;HMC-1: 47.8;HSkMC: 35.0" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB033331: AB_2168044, HPA047815: " "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favourable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavourable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 56.3 26.7 12.5 14.8 14.6 0.6 57.9 10.6 18.5 34.5 30.9 26.1 18.0 17.3 36.8 26.0 18.4 20.4 61.0 33.7 13.4 10.8 34.5 42.0 15.9 17.3 20.8 10.1 16.5 17.6 16.9 10.1 22.4 21.4 82.0 24.7 29.8 9.8 24.0 18.4 16.6 25.4 39.6 28.2 10.2 21.7 18.1 14.5 4.4 32.7 9.6 10.0 43.1 18.1 5.4 13.6 3.3 0.7 2.7 9.5 1.6 1.9 4.8 1.4 2.8 91.2 10.6 2.0 4.3 12.1 2.4 5.6 3.3 3.6 2.0 4.1 27.7 1.2 4.9 2.4 2.7 1.3 3.9 0.2 2.1 4.1 14.4 0.5 47.8 35.0 5.1 3.5 2.2 3.9 0.0 5.5 4.7 1.2 1.3 1.0 3.2 3.9 0.4 2.4 0.1 9.1 15.5 1.7 1.2 4.3 0.8 2.6 3.1 0.3 4.8 0.8 1.4 3.6 3.1 3.4 1.4 2.3 3.2 0.2 3.9 0.0 0.4 3.3 1.5 0.4 1.6 5.4 5.2 3.2 1.9 3.4 9.5 7.5 0.3 2.7 0.7 13.6 2.2 1.6 12.5 14.6 10.6 18.5 13.4 10.8 20.8 10.1 21.4 14.5 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291504 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 38.3;CAPAN-2: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4;MAIT T-cell: 9.4" "Lineage enriched" "Detected in single" 52 "T-cells: 9.4" "Low region specificity" "Detected in many" HPA055540 Uncertain Approved Mitochondria Mitochondria "HPA055540: " "prognostic unfavourable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favourable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 1.4 4.7 8.3 5.3 20.9 0.2 17.5 2.0 11.1 30.4 18.2 28.1 13.4 27.5 7.7 4.1 9.1 38.1 31.2 1.5 13.6 7.1 4.7 1.1 3.7 0.8 37.1 6.5 2.4 19.8 0.6 4.1 1.8 16.6 10.7 15.3 6.7 45.8 19.0 0.3 19.0 21.9 3.3 26.0 1.4 22.2 2.2 25.8 0.7 2.2 5.9 5.0 12.1 5.7 0.0 0.1 0.1 0.0 0.0 9.4 0.3 22.5 38.3 0.5 0.0 0.0 0.1 0.0 2.2 0.0 7.1 5.5 11.0 41.6 0.0 24.5 3.3 12.5 0.0 4.9 3.2 0.2 0.7 0.0 15.4 0.0 8.5 0.0 1.5 1.5 2.1 3.6 4.9 1.2 0.1 0.0 0.0 25.6 0.1 0.0 17.0 0.0 0.0 0.0 0.6 17.9 3.6 4.8 11.5 6.3 10.5 16.5 13.8 0.7 1.2 15.6 10.3 0.1 16.6 0.2 26.2 18.5 4.4 0.0 12.8 0.0 0.0 0.0 4.4 0.0 9.4 0.0 2.0 2.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 8.3 20.9 2.0 11.1 13.6 7.1 37.1 6.5 16.6 25.8 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494747-56645301 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 102.8;ASC TERT1: 51.4;HSkMC: 63.5;U-2197: 93.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 5.4;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 7 "B-cells: 5.4" "HPA028892, HPA072751" Uncertain Supported "Golgi apparatus" "Golgi apparatus" "HPA028892: AB_10602149, HPA072751: " "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favourable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 46.4 17.2 29.0 10.8 30.7 4.2 39.1 13.5 27.5 102.7 15.5 33.8 22.1 8.1 32.7 36.9 20.8 36.7 24.0 23.3 39.9 13.5 30.2 57.7 24.3 6.7 19.2 30.1 27.9 12.2 30.7 7.2 70.9 20.0 37.7 14.4 34.7 22.4 58.7 16.6 24.4 12.5 32.9 16.5 7.9 18.7 23.4 29.7 5.2 107.1 19.4 6.7 35.8 44.0 5.4 0.0 0.8 0.3 0.0 0.0 0.2 0.4 1.5 2.0 0.2 102.8 51.4 4.9 5.4 5.5 5.0 2.5 4.3 0.8 0.7 0.6 8.1 0.8 0.2 0.1 1.0 0.0 1.3 0.1 0.6 6.0 2.5 0.0 0.0 63.5 0.4 4.8 4.0 4.7 0.3 0.0 5.4 0.4 0.0 0.0 6.1 5.9 0.0 0.0 0.2 0.8 4.5 0.0 4.0 1.7 2.2 0.5 0.7 0.0 2.9 25.2 2.1 93.3 0.2 0.0 0.0 0.0 4.4 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 29.0 30.7 13.5 27.5 39.9 13.5 19.2 30.1 20.0 29.7 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell line enhanced" "Detected in some" "BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045188: " "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.1 2.3 1.4 0.1 1.3 0.0 0.0 10.7 0.1 0.9 0.2 1.2 1.4 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 8.7 0.9 2.1 0.9 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 4.4 0.0 0.8 0.2 0.7 0.0 0.7 1.9 0.0 12.0 9.6 5.3 0.5 46.4 0.0 0.0 0.0 8.9 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles Vesicles "HPA055777: " "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favourable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favourable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favourable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavourable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.4 10.9 6.5 13.3 12.8 12.5 9.0 15.6 19.7 8.0 10.5 5.0 8.4 0.4 13.3 16.1 6.1 5.4 11.4 6.9 3.4 3.5 9.6 4.6 14.6 21.8 2.8 11.7 9.8 11.9 11.1 14.6 12.9 0.4 25.2 9.7 11.3 6.3 4.7 9.9 3.7 6.9 4.8 50.8 20.0 7.1 5.2 7.9 6.4 9.9 9.1 21.3 5.4 7.7 5.7 5.0 9.5 4.1 15.7 10.2 1.6 15.6 7.4 9.7 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Approved Nucleoplasm Nucleoplasm "HPA048973: " "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavourable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.7 5.4 3.0 12.5 12.7 12.2 0.8 15.6 14.6 9.7 9.9 1.0 1.6 1.7 9.3 19.9 1.6 1.7 4.7 5.2 4.6 3.2 0.5 3.8 1.0 6.6 0.5 17.8 10.9 8.5 8.3 1.6 6.5 8.4 14.0 8.1 12.9 0.2 2.4 3.3 30.4 0.2 0.4 4.8 4.5 4.1 3.2 10.8 6.5 5.6 3.3 8.1 11.2 7.5 22.0 4.7 37.1 8.2 8.7 5.3 0.6 21.3 8.0 8.6 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 19.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;fHDF/TERT166: 6.7;SH-SY5Y: 14.9;U-138 MG: 7.5;U-87 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 3.8 19.8 4.4 7.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 14.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468938-119494708 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" "Endoplasmic reticulum" Cytosol "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favourable (2.23e-4)" 11.9 12.1 7.6 10.7 12.0 3.9 10.9 13.9 10.6 10.1 9.5 9.8 27.4 5.9 13.7 11.7 9.3 10.1 6.9 8.3 7.3 8.9 8.3 10.3 9.1 14.3 15.0 5.6 10.5 29.2 12.1 14.5 11.5 10.9 9.4 10.9 8.7 7.8 25.7 5.1 14.0 12.1 15.2 14.0 14.9 8.2 4.7 8.9 11.7 8.6 4.1 15.6 10.6 10.2 9.9 14.3 9.4 11.5 19.8 16.0 10.3 7.4 5.0 8.7 9.6 22.0 12.6 6.2 11.9 12.2 9.7 13.3 8.1 4.9 11.5 16.2 15.0 8.8 11.6 11.8 15.4 9.9 7.5 13.5 7.9 8.8 14.3 14.8 15.9 12.9 7.7 9.6 13.5 11.0 7.3 14.1 9.8 7.5 8.4 14.3 8.9 9.2 8.4 8.8 16.9 8.4 9.6 9.5 14.6 5.7 3.6 9.2 9.5 12.4 13.9 9.5 5.9 2.8 6.1 19.4 16.8 15.7 8.3 15.0 13.4 1.9 11.5 9.4 12.0 10.8 13.8 9.9 13.6 12.5 14.3 7.0 16.0 15.2 0.9 19.8 7.0 8.0 14.7 10.3 7.6 12.0 13.9 10.6 7.3 8.9 15.0 5.6 10.9 8.9 POMGNT1 "FLJ20277, LGMD2O, MEB, MGAT1.2" ENSG00000085998 "Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)" Q8WZA1 1 46188682-46220305 "Disease related genes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044518 Approved 6300000 "HPA044518: AB_10795985" "unprognostic (4.59e-3)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (3.20e-1)" "prognostic unfavourable (3.52e-4)" "unprognostic (1.82e-1)" "unprognostic (5.74e-2)" "unprognostic (5.37e-2)" "prognostic favourable (4.27e-4)" "unprognostic (5.86e-2)" "unprognostic (4.39e-2)" "unprognostic (4.99e-3)" "unprognostic (1.72e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" 12.8 17.8 17.9 8.2 26.7 2.8 14.3 12.9 21.6 13.9 9.7 29.5 11.1 12.4 11.7 19.1 9.2 15.8 12.4 43.6 18.8 16.7 19.1 19.2 13.8 7.1 39.4 18.0 10.0 17.2 47.1 19.4 16.6 24.7 21.1 10.7 13.0 13.8 17.2 29.7 13.3 11.3 16.3 36.3 11.7 12.5 16.1 25.0 7.7 22.4 7.5 9.1 11.3 9.0 3.2 6.4 1.6 5.2 9.4 6.2 1.9 13.1 14.1 17.3 16.7 19.1 20.9 22.3 17.7 29.9 24.2 19.1 8.0 11.0 12.2 29.4 29.3 7.5 12.3 25.3 14.6 15.9 14.0 9.6 12.6 12.0 16.7 7.4 9.5 21.0 33.2 27.0 25.2 24.6 11.3 7.9 39.4 9.1 13.0 5.3 14.3 19.8 9.5 17.7 11.4 21.3 16.3 6.5 23.6 16.4 19.0 24.7 12.6 10.5 17.9 18.2 16.2 20.6 33.9 20.1 22.3 5.6 27.8 7.3 19.3 0.0 1.6 1.6 5.1 2.8 3.5 2.1 3.4 4.0 2.2 3.2 6.2 4.8 0.0 9.4 5.2 6.4 3.3 1.9 17.9 26.7 12.9 21.6 18.8 16.7 39.4 18.0 24.7 25.0 PSAP "GLBA, SAP1" ENSG00000197746 Prosaposin P07602 10 71816298-71851375 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid metabolism, Sphingolipid metabolism" "Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2" "Group enriched" "Detected in all" 12 "dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004426, CAB004647" Supported Supported Vesicles "Intracellular and membrane" 86000000 Vesicles "CAB004647: AB_425625, HPA004426: AB_1079701" "unprognostic (4.43e-3)" "unprognostic (2.69e-1)" "unprognostic (1.64e-2)" "unprognostic (8.00e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-3)" "unprognostic (2.79e-1)" "unprognostic (3.31e-2)" "unprognostic (3.25e-2)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (2.34e-1)" "unprognostic (2.06e-1)" 151.5 178.6 106.6 95.1 137.9 79.7 93.3 93.2 143.4 136.7 74.4 134.2 89.5 53.7 116.0 118.2 71.7 88.1 129.7 164.0 99.5 93.7 108.5 119.6 125.5 136.8 135.4 128.0 137.1 93.7 134.8 76.0 165.5 106.7 94.1 73.4 118.2 88.1 117.0 151.6 67.6 63.3 133.5 109.3 159.8 87.4 60.5 126.1 84.4 103.1 54.1 61.4 102.8 76.3 13.4 97.2 80.8 322.1 9.5 12.5 306.2 24.6 46.6 30.3 63.2 296.6 170.6 107.0 44.8 133.4 35.3 42.1 43.0 62.9 13.4 92.5 73.1 54.1 11.4 36.4 25.0 26.1 21.5 15.7 21.1 24.3 114.3 10.2 90.3 108.5 84.1 35.2 67.6 62.6 22.3 65.0 43.7 15.7 44.9 15.3 13.9 22.7 9.4 17.3 37.3 41.1 42.4 33.6 29.7 41.9 127.1 168.9 25.8 23.4 81.3 49.9 35.4 33.3 36.5 72.6 55.1 23.8 79.2 20.4 36.6 19.4 252.0 30.1 12.5 322.1 10.3 13.4 10.3 10.8 97.2 11.8 11.3 10.6 80.8 9.5 263.2 48.5 11.3 306.2 106.6 137.9 93.2 143.4 99.5 93.7 135.4 128.0 106.7 126.1 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favourable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 15.8 7.5 2.2 4.9 8.0 10.6 10.4 10.6 10.7 7.5 7.0 6.2 16.5 11.7 6.2 13.9 10.1 5.2 11.1 7.8 10.2 5.5 16.9 10.1 4.8 9.3 3.8 4.2 6.8 13.1 9.9 12.1 10.5 32.5 17.7 8.0 6.7 1.7 2.2 5.0 7.2 2.8 10.2 4.5 10.9 16.8 3.4 2.7 7.7 7.8 4.0 11.7 1.4 14.6 8.1 9.9 7.7 7.7 6.0 4.7 3.3 10.1 6.4 6.6 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 SGMS2 "MGC26963, SMS2" ENSG00000164023 "Sphingomyelin synthase 2" Q8NHU3 4 107824563-107915047 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "pons and medulla: 17.0" "Group enriched" "Detected in some" 8 "classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0" "Group enriched" "Detected in many" 32 "dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA015076 Supported "HPA015076: AB_1857298" "unprognostic (7.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.36e-2)" "unprognostic (1.87e-2)" "unprognostic (7.88e-3)" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (1.32e-1)" "unprognostic (4.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.82e-3)" "unprognostic (3.26e-1)" "prognostic favourable (1.37e-4)" "unprognostic (6.18e-2)" "unprognostic (5.63e-2)" "unprognostic (8.71e-2)" "unprognostic (5.22e-3)" 7.5 3.3 1.9 8.6 2.9 2.1 8.0 1.7 1.9 8.3 22.2 3.4 5.6 11.4 12.5 9.7 14.9 7.5 24.9 7.8 2.5 2.6 13.2 12.6 20.7 6.4 2.7 1.4 5.4 8.4 4.6 48.5 30.7 17.0 8.0 6.4 11.8 14.2 3.2 5.0 4.5 38.1 18.5 4.6 1.5 9.8 8.6 1.0 0.2 22.0 12.2 5.3 10.7 11.2 0.1 6.6 3.9 5.7 0.0 0.1 1.4 9.9 3.8 0.5 2.9 6.6 15.4 0.2 12.3 9.3 5.8 6.1 1.7 20.7 0.7 4.9 19.4 3.7 7.1 10.8 10.4 2.8 2.8 0.4 8.4 0.5 7.6 6.7 0.0 5.3 7.6 11.3 13.8 12.8 0.1 0.2 9.2 3.3 0.2 0.0 0.3 4.2 0.2 5.0 1.4 15.5 4.9 1.0 0.0 9.3 13.4 1.6 7.2 0.1 21.8 7.0 11.1 10.0 5.6 0.7 0.2 0.4 9.4 1.6 2.9 0.0 5.7 3.9 0.0 2.4 0.0 0.1 0.0 0.0 6.6 0.1 0.1 0.0 0.5 0.0 2.0 0.0 0.0 1.4 1.9 2.9 1.7 1.9 2.5 2.6 2.7 1.4 17.0 1.0 SGPL1 SPL ENSG00000166224 "Sphingosine-1-phosphate lyase 1" O95470 10 70815961-70881173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021125, HPA023086" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA021125: AB_1856803, HPA023086: AB_1856804" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (7.60e-2)" "unprognostic (2.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (1.70e-2)" "unprognostic (2.12e-1)" "unprognostic (9.52e-2)" "unprognostic (3.42e-1)" "unprognostic (2.14e-1)" "unprognostic (9.21e-2)" "unprognostic (4.68e-3)" 9.6 11.2 12.0 20.2 11.4 4.9 24.4 10.8 10.6 16.2 17.1 16.0 21.9 13.3 15.5 16.8 26.7 13.5 13.4 8.3 11.3 9.8 18.2 27.1 10.4 20.1 11.9 9.5 10.0 34.6 15.4 10.2 11.3 10.4 16.1 15.6 7.6 15.0 19.5 7.6 28.6 32.5 12.1 15.7 22.9 10.3 15.3 11.0 14.7 17.6 12.8 18.0 21.4 26.8 5.6 9.7 8.9 24.8 10.9 11.5 6.6 10.5 14.1 13.6 15.5 3.7 4.9 9.0 6.2 6.7 6.8 8.9 15.3 23.4 9.5 7.4 6.3 17.8 11.7 12.5 9.7 15.2 6.2 0.9 7.2 18.2 14.2 4.1 8.6 9.2 21.2 9.1 24.0 4.2 2.8 8.3 9.6 11.7 5.0 2.8 6.1 7.8 6.5 10.4 3.5 10.8 44.8 9.3 11.3 12.4 19.1 11.3 9.9 3.0 8.1 6.1 16.2 4.7 11.9 3.4 4.7 4.4 6.1 7.7 4.3 0.6 11.5 7.9 11.5 20.3 10.4 4.7 7.5 9.4 9.7 5.6 5.7 9.0 8.9 10.9 24.8 5.4 6.8 6.6 12.0 11.4 10.8 10.4 11.3 9.8 11.9 9.5 10.4 11.0 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell line enhanced" "Detected in many" "Daudi: 23.4;U-698: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Enhanced Nucleoplasm Nucleoplasm "HPA053149: , HPA064908: " "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.3 3.3 1.6 4.7 6.0 5.6 19.9 8.5 5.9 5.3 6.0 1.4 5.9 23.4 2.5 4.3 11.0 2.6 5.0 8.6 9.1 3.1 2.1 2.0 2.3 7.4 3.8 6.7 4.1 8.1 4.6 7.3 2.5 1.2 0.6 7.7 3.8 4.4 0.0 1.1 7.2 1.1 4.6 1.8 8.4 5.2 1.0 2.7 5.9 5.6 4.4 7.3 1.4 2.8 7.4 5.1 5.2 4.2 5.6 3.4 30.5 5.4 0.0 3.1 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm Nucleoplasm "HPA042430: AB_10806238, HPA060345: " "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.6 10.2 5.3 6.5 19.7 17.0 10.0 11.0 14.8 13.4 13.1 5.8 15.7 7.6 17.8 9.0 12.5 9.1 10.8 15.1 10.7 9.4 7.8 4.9 11.4 28.4 8.6 6.9 13.5 21.7 7.1 27.6 14.6 6.2 18.2 11.9 9.3 3.5 5.1 5.1 9.9 3.9 5.9 22.7 13.7 9.3 6.2 5.1 9.2 21.5 19.5 6.8 11.0 15.2 7.9 3.9 14.4 11.5 21.5 7.5 8.0 11.3 7.0 11.2 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 SMPD1 ASM ENSG00000166311 "Sphingomyelin phosphodiesterase 1" P17405 11 6390431-6394998 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease mutation, Neurodegeneration, Niemann-Pick disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.6;fHDF/TERT166: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" 2000000 "unprognostic (8.76e-2)" "unprognostic (2.66e-1)" "unprognostic (6.99e-2)" "unprognostic (2.28e-3)" "prognostic unfavourable (7.72e-5)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (4.90e-2)" "unprognostic (8.06e-2)" "unprognostic (1.72e-1)" "prognostic favourable (7.47e-4)" "unprognostic (4.35e-2)" "prognostic favourable (4.57e-6)" "unprognostic (4.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (1.71e-1)" 14.7 21.4 12.4 10.9 18.7 5.4 10.7 17.2 32.4 14.5 17.4 30.6 15.7 14.3 12.2 15.0 11.6 7.9 18.5 26.8 14.5 13.2 47.1 77.5 17.1 10.7 17.4 15.9 12.9 19.9 35.4 23.8 23.1 21.6 17.6 12.9 23.3 21.5 18.5 20.9 19.7 15.8 14.9 17.8 11.7 13.3 7.4 14.1 18.8 20.2 10.3 11.8 12.5 11.4 3.2 1.8 3.4 2.7 6.8 11.4 3.1 4.6 3.7 2.8 7.6 41.6 21.7 5.1 17.6 27.3 8.0 9.7 6.4 3.3 1.2 8.2 41.0 1.9 2.4 3.6 3.8 5.9 2.8 1.4 6.0 1.7 18.6 1.0 11.0 28.6 6.9 7.4 5.0 17.6 2.5 8.8 17.1 4.8 0.0 1.8 1.1 6.6 0.3 1.6 1.9 6.9 1.7 4.9 2.8 7.9 5.5 10.8 2.1 1.9 15.3 29.9 3.2 17.3 4.2 11.3 12.1 1.0 27.7 3.0 13.4 1.8 2.7 3.4 6.9 2.1 5.6 1.6 5.9 5.5 1.4 3.2 11.3 11.4 2.7 6.8 0.6 1.8 4.8 3.1 12.4 18.7 17.2 32.4 14.5 13.2 17.4 15.9 21.6 14.1 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favourable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favourable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.6 5.3 18.3 3.0 11.1 7.5 7.2 9.7 7.3 4.9 6.4 6.4 11.5 5.5 13.2 4.5 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 6.9 10.9 8.7 3.7 12.9 10.0 13.5 1.5 5.0 7.0 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.8 13.4 5.7 11.9 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 5.9 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 SMPD3 NSMASE2 ENSG00000103056 "Sphingomyelin phosphodiesterase 3" Q9NY59 16 68358325-68448688 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Lipid metabolism, Sphingolipid metabolism" "Developmental protein, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0" "Cell line enhanced" "Detected in some" "HMC-1: 9.4;MOLT-4: 13.4;RPMI-8226: 11.1;SCLC-21H: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "plasmacytoid DC: 44.5" "Lineage enriched" "Detected in many" 7 "dendritic cells: 44.5" "Region enhanced" "Detected in many" "basal ganglia: 103.1" "Low region specificity" "Detected in all" "CAB033885, HPA065535, HPA069383" Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB033885: AB_1126788, HPA065535: , HPA069383: " "unprognostic (1.21e-1)" "prognostic favourable (7.72e-4)" "unprognostic (5.61e-3)" "prognostic favourable (3.86e-4)" "unprognostic (2.46e-1)" "unprognostic (5.85e-4)" "unprognostic (7.87e-2)" "unprognostic (8.12e-3)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-3)" "unprognostic (5.02e-3)" "unprognostic (2.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.93e-3)" 3.5 2.3 6.0 3.1 18.3 1.8 1.6 9.4 15.4 1.0 9.6 2.5 0.0 46.4 1.7 0.7 1.8 2.7 17.2 1.2 8.7 3.6 0.9 3.8 2.1 3.5 2.5 5.0 2.7 1.9 0.7 10.7 0.8 3.9 2.2 5.8 4.3 2.2 0.9 1.8 8.1 42.7 1.2 1.4 3.0 18.6 4.2 4.4 73.0 1.3 1.3 4.3 1.6 1.2 0.6 44.5 6.1 0.0 0.0 0.7 0.3 0.3 0.7 0.3 0.1 0.0 0.0 5.2 0.4 0.0 0.4 0.1 2.9 0.9 0.4 0.5 0.2 1.1 0.0 0.0 0.1 0.3 0.7 0.1 2.1 0.3 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.3 0.2 13.4 2.5 0.6 0.1 0.6 0.2 11.1 0.0 0.1 12.9 2.5 0.4 1.5 0.6 1.0 0.8 0.0 0.4 0.8 1.4 0.1 2.1 1.1 0.2 0.2 0.8 0.2 1.0 0.0 6.1 0.7 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 44.5 0.5 0.3 6.0 18.3 9.4 15.4 8.7 3.6 2.5 5.0 3.9 4.4 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA046279: , HPA049426: " "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavourable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.73e-4)" "prognostic unfavourable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 31.7 15.7 19.8 14.6 10.2 7.5 25.8 16.9 12.6 25.0 20.9 45.4 16.3 20.7 15.0 17.0 18.1 25.3 22.4 17.4 27.4 24.4 23.3 16.9 36.0 8.7 26.0 14.9 8.8 15.0 28.0 11.2 14.4 28.9 16.8 13.9 17.2 27.1 13.1 30.4 20.9 28.8 15.1 22.5 10.6 15.1 27.6 15.4 16.7 20.4 7.4 13.9 11.4 11.1 21.4 20.8 14.0 19.8 14.7 16.4 27.8 19.3 14.9 15.2 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 33.7;U-251 MG: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 11.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavourable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 9.3 2.2 4.7 10.5 3.5 15.0 20.4 0.4 3.2 5.5 5.0 4.0 0.4 1.9 6.3 8.3 13.8 5.3 12.7 10.5 5.3 2.1 4.1 2.4 12.9 10.1 4.4 1.5 5.5 15.1 3.1 2.7 7.4 4.7 4.3 1.1 11.0 11.5 1.7 6.8 8.7 6.3 5.2 4.0 2.7 3.8 3.7 6.3 3.0 9.4 16.2 12.1 5.6 7.0 0.2 8.0 2.4 3.4 0.1 1.4 1.3 9.6 1.0 4.2 0.2 2.1 2.0 4.4 22.3 14.8 18.8 11.4 5.2 1.0 0.4 2.0 16.4 2.0 3.2 28.6 4.6 0.4 1.7 0.1 7.1 33.7 4.7 0.3 0.8 3.8 0.5 29.3 11.6 18.1 4.5 0.0 3.7 12.3 0.9 0.1 0.2 8.1 0.6 1.1 0.7 1.0 0.1 0.5 1.0 2.2 0.2 19.3 0.8 1.3 29.4 29.6 5.7 22.7 37.7 0.4 0.1 0.4 22.5 1.7 4.4 2.4 3.4 0.0 1.4 1.7 0.4 0.0 0.2 0.4 1.0 0.2 0.0 0.3 0.4 0.1 0.3 8.0 0.0 1.3 4.7 3.5 0.4 3.2 5.3 2.1 4.4 1.5 4.7 6.3 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065508 Supported Vesicles Vesicles "HPA065508: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavourable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favourable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favourable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.3 8.9 12.6 9.9 13.0 5.2 5.1 13.6 22.0 7.2 12.9 13.4 4.9 33.2 7.4 4.2 4.9 7.3 7.8 4.7 22.5 14.8 19.3 15.2 6.1 8.7 26.3 14.9 9.1 7.2 15.0 9.5 4.1 22.3 8.7 6.2 7.2 7.5 8.0 6.1 4.3 22.2 4.9 14.1 8.4 11.3 17.2 13.7 4.0 9.1 3.1 5.3 6.2 12.4 10.4 7.4 12.5 9.4 7.2 7.0 4.2 4.0 11.7 4.4 8.0 4.8 2.0 8.3 4.4 3.7 5.2 6.2 20.0 5.4 7.6 3.0 2.8 3.0 4.1 3.6 0.7 8.6 9.6 8.4 5.1 7.0 7.6 5.4 9.3 3.7 1.9 3.6 2.5 2.8 5.5 6.8 2.5 4.2 12.6 33.3 5.8 5.7 11.7 3.5 4.9 2.4 2.7 15.9 12.6 4.2 6.7 4.2 3.6 3.6 4.5 7.4 4.1 5.8 8.8 13.1 15.1 8.4 4.3 6.2 6.7 12.5 8.3 3.6 6.0 9.4 5.9 6.5 4.8 5.8 7.4 10.4 6.6 7.0 3.3 7.2 7.4 6.6 4.6 4.2 12.6 13.0 13.6 22.0 22.5 14.8 26.3 14.9 22.3 13.7 SPTLC1 "hLCB1, HSAN1, HSN1, LCB1, SPTI" ENSG00000090054 "Serine palmitoyltransferase long chain base subunit 1" O15269 9 92000087-92115384 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010860, CAB018747, HPA063907" Supported Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: " "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.06e-1)" "unprognostic (3.55e-3)" "unprognostic (8.37e-2)" "prognostic favourable (1.36e-6)" "unprognostic (1.13e-1)" "unprognostic (2.41e-2)" "unprognostic (4.28e-1)" "unprognostic (1.49e-1)" 16.4 17.7 13.3 11.4 17.1 9.9 16.8 19.9 17.6 20.3 17.2 20.9 18.1 14.0 17.3 15.1 30.5 19.2 15.5 11.4 13.9 15.3 19.0 13.5 14.8 10.6 18.0 12.2 35.3 15.8 23.6 23.1 28.3 20.5 14.5 18.8 12.0 18.5 13.3 9.4 20.1 17.8 15.1 20.8 10.7 16.0 19.8 14.1 9.7 26.2 16.0 16.5 17.4 20.9 9.3 21.0 21.1 22.1 10.2 15.2 16.0 18.1 16.4 11.4 9.5 27.9 21.7 19.7 19.1 24.4 16.5 17.9 10.3 37.9 10.0 12.2 24.1 47.6 12.3 16.2 19.2 11.5 7.1 9.2 9.3 10.0 21.0 15.2 12.5 19.6 19.6 17.0 18.6 15.0 21.5 12.5 18.7 19.5 9.5 3.8 15.3 12.0 10.6 13.8 7.6 16.4 11.1 9.3 8.6 25.7 19.7 11.6 10.1 9.0 19.0 16.1 12.4 18.5 13.3 9.0 12.3 5.6 19.2 7.5 19.3 14.6 22.1 11.9 11.5 21.6 11.0 8.9 11.6 11.6 21.0 9.3 14.2 10.7 21.1 10.2 19.2 10.8 15.2 16.0 13.3 17.1 19.9 17.6 13.9 15.3 18.0 12.2 20.5 14.1 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favourable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 11.9 7.9 6.1 6.6 6.3 7.9 10.3 17.8 13.2 12.3 12.9 10.0 26.7 12.0 4.5 18.1 14.8 16.1 10.0 18.7 5.2 4.7 33.9 6.1 5.9 5.3 3.4 11.3 5.1 4.9 8.0 8.9 17.3 6.6 5.8 7.0 10.3 9.0 11.7 3.9 7.1 9.7 6.2 4.1 14.2 26.9 5.9 7.4 6.4 21.5 6.7 26.4 6.3 10.8 11.3 8.1 4.1 4.1 3.3 5.4 8.1 7.5 12.2 6.4 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.0;RPTEC TERT1: 21.4;U-2197: 14.9;U-87 MG: 28.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules Microtubules "HPA044247: , HPA048079: " "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favourable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.6 1.1 0.8 0.0 7.0 10.1 5.4 0.0 1.5 1.0 4.1 8.7 4.4 0.0 0.5 0.2 12.0 0.0 3.3 1.4 0.0 0.0 0.0 2.8 12.3 0.6 0.0 0.1 5.7 10.4 4.0 1.3 0.6 0.0 16.0 11.3 0.2 0.0 0.0 0.0 1.4 1.1 2.0 7.0 21.4 8.6 0.0 0.1 0.1 1.1 0.0 8.9 0.2 1.5 4.5 1.5 14.9 1.0 0.1 0.0 0.0 28.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 ST3GAL1 "SIAT4A, SIATFL, ST3GalA.1, ST3O" ENSG00000008513 "ST3 beta-galactoside alpha-2,3-sialyltransferase 1" Q11201 8 133454848-133571940 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 47.8;RT4: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040466 Approved "Intracellular and membrane" 290000 "HPA040466: AB_10805712" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.66e-2)" "unprognostic (1.83e-3)" "unprognostic (5.53e-3)" "unprognostic (4.43e-2)" "unprognostic (4.79e-2)" "unprognostic (2.66e-1)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (1.10e-1)" "unprognostic (1.83e-3)" "unprognostic (1.67e-2)" "unprognostic (3.29e-2)" "unprognostic (8.64e-3)" "unprognostic (2.95e-2)" 14.4 14.4 5.1 11.8 3.6 10.2 7.8 3.7 6.5 9.8 5.4 4.1 18.1 1.8 8.5 11.8 9.0 9.0 17.0 35.4 4.2 3.4 23.1 44.5 11.9 12.4 4.7 2.5 10.3 8.2 4.4 7.6 49.8 6.4 7.1 2.9 11.2 18.2 15.1 20.9 4.0 6.5 12.3 3.9 17.3 9.4 5.0 1.4 6.3 40.2 7.9 16.8 14.0 14.3 22.7 7.0 21.3 9.8 21.9 19.9 9.5 4.7 2.5 1.0 2.9 10.3 5.4 5.3 5.4 13.1 2.1 1.6 4.4 5.3 1.1 3.7 10.0 1.4 3.4 4.0 1.9 13.3 0.6 9.9 7.6 8.8 7.9 2.0 7.9 6.3 2.0 7.6 4.2 9.2 0.1 15.4 1.5 5.0 2.8 2.7 0.7 47.8 3.3 1.3 8.1 0.9 36.8 0.2 0.8 2.4 8.2 2.5 1.5 2.7 8.9 6.5 10.3 5.6 2.3 19.0 13.6 1.2 14.8 6.9 6.6 20.5 4.7 21.3 14.4 4.5 13.3 12.8 14.6 16.4 2.9 22.7 19.9 18.5 8.6 21.9 9.8 7.0 8.9 9.5 5.1 3.6 3.7 6.5 4.2 3.4 4.7 2.5 6.4 1.4 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375978-70439237 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Approved Vesicles "Intracellular and membrane" Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favourable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavourable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 12.6 9.1 9.3 17.2 11.9 14.3 8.9 24.1 10.6 11.3 8.8 5.1 9.3 9.2 13.9 5.6 5.8 9.0 6.8 9.2 10.4 6.0 8.8 12.9 9.3 14.9 5.1 4.7 13.6 4.2 8.8 7.2 8.8 6.8 7.5 4.7 9.9 4.9 9.0 33.3 6.0 10.5 12.0 4.0 17.7 5.4 9.6 5.9 16.0 6.6 4.9 12.6 9.1 12.0 3.2 14.3 11.2 2.2 2.8 4.2 1.1 1.4 8.3 7.2 9.6 3.9 5.3 1.7 5.9 6.3 6.6 3.3 4.9 3.3 4.0 10.6 6.4 1.0 2.9 2.4 3.1 9.5 4.6 17.2 3.4 7.4 4.8 6.2 28.3 4.1 1.4 6.6 1.2 9.0 23.4 3.9 3.6 0.6 6.6 17.1 9.8 4.5 12.6 2.7 5.4 4.4 1.1 3.2 9.5 14.7 0.3 6.5 1.6 7.0 9.6 8.4 10.0 3.5 4.3 8.2 3.2 8.2 9.1 5.2 11.6 2.7 2.0 5.7 2.0 2.2 1.9 1.7 2.4 2.2 1.0 3.2 4.2 3.3 11.2 2.8 1.3 14.3 2.7 1.1 9.3 11.9 24.1 10.6 10.4 6.0 5.1 4.7 6.8 5.9 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 44.7;WM-115: 101.5" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049827 Approved "Intracellular and membrane" "HPA049827: " "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.8 4.0 3.2 2.7 9.4 7.8 7.9 5.6 10.9 5.1 3.5 2.3 8.4 1.4 4.3 8.9 7.6 6.6 3.7 4.0 5.2 1.9 12.4 10.1 2.7 6.1 14.8 25.4 6.2 5.9 7.7 12.2 6.8 7.7 3.7 6.3 20.0 4.7 15.2 2.0 26.5 4.8 9.8 0.6 1.1 14.0 6.0 3.8 6.2 37.7 44.7 13.1 9.8 2.5 12.3 2.8 8.7 10.6 0.3 0.8 0.7 5.6 22.8 101.5 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;RT4: 21.7;SK-MEL-30: 17.9;U-266/84: 18.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles Vesicles "HPA034708: AB_10601594, HPA040425: , HPA068928: " "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favourable (4.99e-4)" "prognostic favourable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.5 1.1 25.6 10.6 5.7 3.8 2.7 8.4 2.7 2.4 0.2 9.1 0.3 0.0 4.6 0.4 1.6 2.9 3.3 0.1 1.5 0.2 0.5 0.4 8.5 0.1 3.7 3.2 0.4 1.0 0.4 6.4 0.3 14.2 8.6 0.8 0.8 1.4 0.1 0.0 1.6 8.1 5.0 1.4 21.7 1.8 1.8 0.1 0.0 17.9 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.3 18.9 0.2 2.0 2.6 12.9 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 ST6GALNAC2 "SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM" ENSG00000070731 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2" Q9UJ37 17 76565379-76586956 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 78.2" "Cell line enhanced" "Detected in some" "BEWO: 9.4;HaCaT: 11.5;HBEC3-KT: 10.5;hTCEpi: 29.3;MCF7: 11.3;SK-MEL-30: 38.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 19.2" "Cell type enriched" "Detected in some" 9 "neutrophil: 23.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 23.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048849 Uncertain "Intracellular and membrane" "HPA048849: " "unprognostic (8.93e-3)" "unprognostic (5.86e-3)" "unprognostic (1.67e-2)" "unprognostic (5.18e-3)" "unprognostic (3.37e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.95e-1)" "unprognostic (5.37e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (6.48e-4)" "unprognostic (1.57e-1)" "unprognostic (5.17e-3)" "unprognostic (3.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 4.3 1.7 0.6 2.7 1.8 0.4 7.0 0.4 1.3 8.6 7.2 6.0 3.6 0.4 2.6 8.8 17.2 28.3 2.1 4.6 2.1 1.3 10.6 1.3 11.3 1.7 4.0 1.0 5.0 3.6 1.5 2.1 18.3 19.2 6.7 3.4 78.2 6.6 6.1 11.3 27.3 2.5 4.7 3.7 2.0 3.5 17.1 1.3 0.7 17.7 12.4 6.9 8.3 7.6 0.0 0.2 23.5 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.6 11.5 0.1 10.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 29.3 0.0 3.3 0.0 0.0 0.0 0.1 11.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 0.1 0.0 1.3 0.0 38.1 7.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.1 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.5 0.0 0.1 0.0 0.0 0.1 0.6 1.8 0.4 1.3 2.1 1.3 4.0 1.0 19.2 1.3 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 18.2;HUVEC TERT2: 23.1;SK-MEL-30: 31.5;TIME: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA054566: , HPA055399: " "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.2 0.0 0.3 0.0 0.0 0.0 2.1 0.3 0.2 5.8 0.0 0.3 1.2 0.1 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.8 0.8 0.0 0.0 0.0 1.4 4.5 0.0 0.0 31.5 0.0 0.1 10.2 0.1 1.4 0.0 1.6 0.0 0.0 0.0 0.0 4.1 2.7 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell line enhanced" "Detected in many" "HDLM-2: 34.9;RPMI-8226: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.1 5.4 1.4 6.9 9.7 7.4 1.0 5.5 6.1 5.6 3.3 3.0 5.8 20.1 8.4 6.8 7.7 2.8 5.8 0.9 34.9 2.4 6.4 17.2 11.4 11.9 0.5 6.7 9.1 6.2 5.0 4.5 14.9 4.6 13.5 2.7 1.4 1.2 0.7 1.6 13.3 6.0 3.6 49.4 5.7 0.1 11.8 2.6 8.0 17.3 1.0 3.5 4.1 10.6 4.6 5.3 14.3 8.6 21.9 11.3 6.3 9.2 2.8 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell line enhanced" "Detected in some" "AF22: 9.0;fHDF/TERT166: 10.6;HaCaT: 5.1;SH-SY5Y: 7.7;U-2 OS: 8.8;U-251 MG: 4.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA065593: , HPA070354: " "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.3 0.0 9.0 0.0 0.0 0.0 0.0 0.8 3.1 2.6 0.8 0.0 0.2 0.0 0.0 10.6 5.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 8.8 0.0 4.9 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 ST6GALNAC6 "SIAT7F, ST6GALNACVI" ENSG00000160408 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6" Q969X2 9 127885321-127905408 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "NK-cells: 12.7;T-cells: 16.0" HPA018890 Approved "Intracellular and membrane" "HPA018890: AB_1857531" "unprognostic (2.27e-1)" "unprognostic (5.23e-2)" "unprognostic (2.81e-1)" "unprognostic (4.54e-2)" "unprognostic (1.81e-2)" "unprognostic (5.71e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.24e-3)" "unprognostic (3.31e-2)" "unprognostic (3.29e-1)" "unprognostic (1.10e-2)" "unprognostic (9.85e-2)" "unprognostic (3.46e-2)" "unprognostic (2.67e-2)" 39.3 12.9 45.1 9.7 40.8 7.7 59.6 23.4 37.4 17.2 44.5 8.7 18.6 5.5 14.8 27.3 21.0 31.1 17.8 22.8 38.2 17.0 13.2 18.1 23.5 13.7 18.3 28.3 39.4 19.1 12.7 7.8 10.8 13.6 12.8 72.9 9.6 14.5 22.0 18.9 9.8 9.8 21.9 9.6 18.7 12.1 6.9 15.9 2.3 9.6 9.1 11.2 16.7 29.2 3.3 1.1 2.7 2.8 12.7 16.0 6.5 3.5 3.3 6.4 11.6 52.0 28.1 2.5 9.2 21.1 13.5 11.0 5.4 3.0 3.7 4.0 20.9 6.1 8.3 6.8 6.2 17.5 4.6 3.8 5.3 5.6 13.6 1.1 6.3 28.5 8.4 9.8 4.4 13.3 3.6 4.5 17.3 3.0 2.3 6.0 2.8 5.8 7.2 8.0 4.4 10.7 0.7 4.1 6.0 6.3 2.6 2.3 3.0 7.7 8.0 8.0 4.8 8.8 5.0 5.5 3.4 6.8 7.5 1.3 2.7 2.7 0.7 0.1 16.0 1.1 11.7 3.3 10.3 11.5 1.0 2.6 6.5 8.4 0.4 12.7 2.8 1.1 15.3 6.5 45.1 40.8 23.4 37.4 38.2 17.0 18.3 28.3 13.6 15.9 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell line enhanced" "Detected in some" "AF22: 9.0;ASC TERT1: 6.0;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 8.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 1.7 7.6 7.0 5.3 6.2 2.3 5.9 20.2 13.0 3.5 5.4 2.3 2.3 0.4 4.5 1.4 3.0 2.3 2.4 4.4 7.6 8.5 1.1 0.6 3.8 8.6 7.6 6.5 2.6 1.2 7.2 0.6 0.4 9.4 6.6 3.5 1.5 3.2 4.4 1.0 4.3 2.1 6.3 10.9 2.7 2.1 1.0 4.8 0.2 1.4 0.5 9.2 6.7 3.1 0.3 0.2 1.2 0.2 0.3 3.0 0.6 0.0 0.5 9.0 0.0 1.4 6.0 0.9 0.0 0.0 0.1 0.4 0.3 0.1 1.1 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 1.1 0.1 0.1 0.0 0.3 0.1 0.5 0.9 0.1 0.9 0.2 0.0 0.6 0.2 0.0 1.2 0.3 2.3 0.0 0.0 0.2 0.2 4.6 0.0 0.1 0.2 0.0 0.1 8.3 0.7 0.1 0.0 0.7 0.9 0.1 1.4 0.7 0.5 0.7 1.4 0.1 8.9 1.2 0.2 0.2 0.4 0.1 0.9 0.1 2.9 2.3 0.1 0.3 0.4 1.0 0.9 0.3 0.2 0.2 3.0 0.6 7.0 6.2 20.2 13.0 7.6 8.5 7.6 6.5 9.4 4.8 ST8SIA4 "PST, PST1, SIAT8D" ENSG00000113532 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4" Q92187 5 100806935-100903266 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.1;lymphoid tissue: 34.7" "Cell line enhanced" "Detected in many" "AF22: 18.7;HDLM-2: 30.2;Karpas-707: 26.0;NB-4: 12.2;RPMI-8226: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051126, HPA053995" Approved Approved "Golgi apparatus" "Intracellular and membrane" 580000 "Golgi apparatus" "HPA051126: , HPA053995: " "unprognostic (2.25e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.14e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-1)" "unprognostic (5.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.49e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (7.80e-7)" "unprognostic (6.07e-2)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" 11.7 2.7 4.3 16.7 4.3 8.2 6.5 1.3 4.2 3.4 5.3 2.6 0.3 4.0 2.3 4.2 4.3 3.5 6.5 4.7 4.0 8.0 2.6 3.3 17.5 27.9 5.1 1.7 2.5 2.1 1.5 2.4 13.7 11.6 3.4 5.6 2.7 4.0 1.3 2.0 2.1 7.7 3.6 8.0 31.6 3.7 1.6 4.3 34.7 4.9 0.8 13.8 7.4 3.5 4.7 4.9 37.1 8.9 4.0 6.9 4.4 0.0 2.7 18.7 0.0 1.2 1.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 30.2 0.0 1.1 0.2 0.0 0.0 5.6 2.3 1.5 0.0 0.0 0.0 3.4 0.0 26.0 1.1 0.2 7.9 12.2 0.1 0.1 4.5 0.3 19.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.1 1.2 0.2 0.1 0.0 0.2 8.5 8.7 1.7 0.4 7.0 2.3 18.8 7.5 8.9 5.7 8.8 4.3 4.7 3.8 4.7 4.9 3.6 2.4 4.5 37.1 4.0 8.9 1.5 6.9 4.4 4.3 4.3 1.3 4.2 4.0 8.0 5.1 1.7 11.6 4.3 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell line enriched" "Detected in some" 8 "WM-115: 51.7" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" "Plasma membrane, Midbody" "HPA043813: , HPA046771: " "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 51.7 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favourable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavourable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 20.7 18.9 24.2 33.2 45.6 35.4 26.0 38.0 45.4 31.0 38.8 57.5 56.2 27.1 46.2 55.9 38.4 33.5 33.3 41.2 21.1 17.8 63.8 13.1 39.7 50.5 38.1 29.9 27.3 24.2 42.8 83.7 34.5 26.8 40.6 39.0 15.3 15.3 12.2 15.5 20.6 18.2 20.6 40.7 33.8 32.3 15.1 13.0 26.9 44.0 13.5 51.5 27.5 30.8 44.6 16.1 18.8 29.8 12.8 14.9 20.9 17.2 38.6 35.4 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 STT3B "FLJ90106, SIMP, STT3-B" ENSG00000163527 "STT3B, catalytic subunit of the oligosaccharyltransferase complex" Q8TCJ2 3 31532638-31637622 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036448, HPA036646" Approved Supported "Endoplasmic reticulum" 9300 "Endoplasmic reticulum" "HPA036448: , HPA036646: AB_10673472" "unprognostic (2.17e-2)" "unprognostic (2.23e-1)" "prognostic favourable (7.91e-5)" "unprognostic (1.60e-1)" "unprognostic (3.11e-1)" "unprognostic (2.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.04e-1)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (3.68e-2)" "unprognostic (3.86e-2)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (6.71e-3)" "unprognostic (1.02e-1)" 23.0 30.3 16.0 27.5 16.7 21.7 27.4 15.4 19.4 28.4 25.0 16.9 37.0 18.6 28.4 37.9 28.8 22.4 29.0 27.5 15.1 15.6 28.2 64.1 30.1 36.9 16.5 15.5 62.3 39.4 36.2 20.3 85.9 16.5 26.3 25.1 22.3 25.2 26.3 31.2 19.2 29.2 23.2 19.7 29.4 22.9 36.7 13.6 60.2 44.3 23.4 30.3 27.5 27.7 3.6 7.7 8.4 5.3 8.4 8.5 3.0 16.3 27.5 25.3 26.5 31.9 32.3 55.4 30.7 27.0 23.0 26.7 25.0 35.6 28.5 15.1 27.8 13.9 23.4 26.6 30.2 80.2 15.4 24.4 28.0 26.6 24.6 52.5 29.1 24.7 28.6 32.7 41.4 23.2 13.1 45.7 31.3 9.2 51.4 32.5 20.4 15.5 53.8 13.7 41.3 26.8 23.7 10.8 13.2 30.4 45.2 17.8 20.4 28.1 45.1 31.1 19.9 30.7 27.0 28.8 34.5 23.9 28.2 36.2 25.5 2.3 4.6 8.4 4.7 5.3 7.5 3.4 8.5 6.5 4.0 3.6 8.2 6.5 1.7 8.4 3.7 7.7 4.1 3.0 16.0 16.7 15.4 19.4 15.1 15.6 16.5 15.5 16.5 13.6 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "BEWO: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.2 1.7 1.0 1.5 1.2 1.0 25.0 0.5 0.9 1.5 0.9 2.4 3.4 0.7 1.1 1.5 1.3 1.6 1.4 2.4 3.7 0.6 3.0 1.6 1.8 0.8 2.6 4.4 1.1 1.1 1.9 1.3 1.7 2.2 2.6 1.1 1.1 1.0 1.2 0.9 1.0 1.2 0.5 1.6 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 3.7 2.4 2.2 2.8 1.2 2.3 2.1 1.3 0.4 2.8 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 UGCG GCS ENSG00000148154 "UDP-glucose ceramide glucosyltransferase" Q16739 9 111896766-111935369 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 19 "plasmacytoid DC: 39.7" "Lineage enriched" "Detected in many" 19 "dendritic cells: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024124 Approved "HPA024124: AB_1858595" "unprognostic (1.22e-2)" "prognostic favourable (6.62e-4)" "unprognostic (5.39e-2)" "prognostic favourable (4.44e-5)" "unprognostic (1.53e-2)" "unprognostic (9.70e-2)" "unprognostic (3.20e-2)" "unprognostic (2.04e-1)" "unprognostic (3.40e-1)" "unprognostic (1.31e-1)" "unprognostic (1.95e-2)" "unprognostic (3.22e-1)" "unprognostic (9.84e-3)" "unprognostic (2.24e-2)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (3.77e-2)" 33.7 37.7 5.9 21.4 7.8 55.2 20.5 9.5 11.2 14.6 19.6 5.0 3.3 13.3 10.6 8.6 34.0 11.1 24.5 17.5 8.6 9.0 23.8 18.4 28.1 35.4 7.1 5.8 15.9 11.4 3.5 11.9 15.3 6.8 12.4 10.5 11.9 10.8 5.4 14.0 21.7 25.5 12.4 12.9 33.1 26.1 11.7 6.2 17.9 8.5 16.9 27.7 34.2 25.9 2.0 39.7 0.4 0.3 0.5 1.2 0.5 24.1 2.6 4.2 2.8 9.2 11.1 2.2 15.1 16.0 17.8 24.1 5.1 18.6 5.7 12.0 10.0 12.4 4.9 6.5 19.1 2.3 2.8 2.3 3.9 2.5 6.6 2.5 3.7 11.0 5.1 16.9 24.4 5.4 12.6 11.1 52.4 4.1 2.7 2.8 4.8 2.7 3.2 30.2 1.8 40.9 9.2 2.0 3.2 6.7 5.7 16.6 30.5 2.6 25.5 8.2 4.2 22.9 10.8 2.1 7.6 2.6 10.1 1.6 11.1 0.0 0.1 0.0 0.4 0.2 0.7 1.6 0.8 0.6 0.6 2.0 0.7 0.7 0.4 0.5 0.3 39.7 1.2 0.5 5.9 7.8 9.5 11.2 8.6 9.0 7.1 5.8 6.8 6.2 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol 3800000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavourable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 13.7 14.7 7.6 16.4 10.2 23.8 11.3 10.7 10.8 12.7 15.2 10.0 21.1 11.4 12.3 26.3 13.1 10.6 11.3 13.0 7.7 7.9 13.7 33.4 13.9 14.6 11.0 5.7 10.4 44.1 13.4 11.2 22.1 9.1 11.7 13.5 9.7 15.5 20.5 19.3 11.1 17.4 8.9 9.0 16.1 13.0 9.9 9.5 24.3 13.8 6.4 15.7 11.4 11.0 6.3 7.4 8.8 6.2 4.7 5.9 2.8 16.2 5.7 10.9 23.4 14.4 11.5 16.6 18.8 8.2 6.3 5.7 12.6 12.1 23.1 7.5 13.8 12.1 8.3 8.2 12.9 14.6 4.0 20.3 7.5 38.4 14.3 27.1 12.8 8.4 6.5 12.7 11.6 14.6 13.0 12.6 13.3 11.4 10.9 15.6 19.3 5.9 9.0 10.4 9.8 11.7 12.1 5.7 8.6 13.0 17.8 11.0 7.0 19.2 20.1 17.4 11.9 9.9 13.4 13.2 18.3 10.7 14.8 14.9 16.0 7.1 6.2 5.4 5.9 6.0 5.8 4.0 4.8 5.3 4.5 6.3 4.1 5.9 8.8 4.7 5.7 7.4 3.8 2.8 7.6 10.2 10.7 10.8 7.7 7.9 11.0 5.7 9.1 9.5 UGGT2 "FLJ10873, FLJ11485, HUGT2, MGC117360, MGC150689, MGC87276, UGCGL2" ENSG00000102595 "UDP-glucose glycoprotein glucosyltransferase 2" Q9NYU1 13 95801580-96053482 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047955 Uncertain "Intracellular and membrane" "HPA047955: " "unprognostic (5.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.51e-2)" "unprognostic (1.83e-1)" "unprognostic (9.33e-2)" "unprognostic (8.70e-2)" "prognostic unfavourable (9.99e-4)" "prognostic unfavourable (5.47e-4)" "unprognostic (1.55e-1)" "unprognostic (9.21e-2)" "unprognostic (7.75e-3)" "unprognostic (6.27e-2)" "unprognostic (5.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.61e-2)" 19.7 11.5 9.7 8.0 12.0 5.4 16.3 2.8 13.6 14.2 11.2 11.2 10.2 8.9 17.8 26.6 8.1 13.5 10.1 16.6 11.2 10.9 12.9 13.4 11.8 6.7 10.4 8.9 15.1 16.9 11.7 26.4 17.6 14.3 12.8 10.4 12.4 12.6 15.2 15.4 8.7 8.4 16.1 17.4 8.7 12.8 18.3 11.2 0.0 18.4 5.0 4.8 15.3 14.8 1.5 4.5 3.0 7.7 1.2 0.2 2.2 11.3 5.5 11.4 6.0 19.1 20.5 9.5 19.4 14.5 9.1 15.7 8.3 9.9 3.9 7.2 12.3 7.2 3.9 4.1 13.3 0.1 5.4 5.0 11.8 5.5 11.2 13.8 12.5 12.1 4.3 3.5 10.8 8.1 3.3 6.6 12.6 3.7 0.1 6.1 4.8 3.2 0.0 8.2 5.7 7.9 11.5 2.4 9.4 10.5 10.6 8.0 9.3 6.7 14.2 9.1 6.1 10.3 9.8 9.3 4.7 4.9 24.2 7.5 12.2 0.3 7.5 3.0 0.2 7.7 0.1 1.5 0.1 0.1 4.5 0.6 0.1 0.1 0.5 1.2 6.9 0.3 0.0 2.2 9.7 12.0 2.8 13.6 11.2 10.9 10.4 8.9 14.3 11.2